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Antimicrobial resistance (AMR) is a major worldwide issue with severe 
implications on human and animal health as well as global food security. For this 
study, 223 (41 locally recruited and 182 through the Dog’s Trust Generation Pup 
study) 16-week-old puppies, 64 locally recruited 12-week-old puppies and 25 
adult dogs (14 locally recruited and 11 recruited from the Oxfordshire area) were 
screened and their owners provided a faecal sample from their dog and 
completed a questionnaire. The E. coli (Escherichia coli) carried by these puppies 
were tested for resistance to five different antimicrobials (ciprofloxacin, 
streptomycin, tetracycline, cephalexin and amoxicillin). Univariable and 
multivariable logistic regression analyses were used to explore possible risk 
factors for AMR in E. coli carried by the puppies. Puppies that were fed raw meat 
had a greater risk of ciprofloxacin resistance (multivariable: 12.42 (5.01 to 30.78) 
<0.001), tetracycline resistance (multivariable: 4.47 (2.21 to 9.05) <0.001), 
amoxicillin resistance (multivariable: 3.18 (1.57 to 6.42) 0.001) and streptomycin 
resistance (multivariable: 8.23 (3.95 to 17.15) <0.001). Autocoprophagia was 
found to be protective against resistance in the Generation Pup cohort to 
tetracycline (multivariable: 0.10 (0.01 to 0.80) 0.03) and amoxicillin (multivariable: 
0.18 (0.04 to 0.82) 0.03). The cephalexin resistant E. coli were screened for 
cefotaxime resistance and further molecular methods were carried out on these. 
The PCR and whole genome sequence results from the cefotaxime- and 
ciprofloxacin-resistant E. coli carried by the puppies showed that there were a 
variety of sequence types (ST’s) identified and provided the mechanism for 
resistance. For the local cohort of puppies’ samples were collected at 12 and 16 
weeks to allow for comparison of resistance. Amoxicillin resistance in the E. coli 
isolated from the 12-week-old puppies was higher in comparison to the 16-week-
old puppies (p<0.001). There was evidence of regional variation in resistance 
depending on the recruitment area. Tetracycline (p=0.05) and amoxicillin 
(p=0.04) resistance were more common in E. coli isolated from the 16-week-old 
puppies that were locally recruited compared to those that were recruited 
nationally. Furthermore, adult dogs recruited from the Oxfordshire area (n=11) 
were more likely to have amoxicillin resistance compared to locally recruited dogs 
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Chapter 1 – Introduction 
 
1.1 Antimicrobial Resistance (AMR) 
 
Antimicrobial resistance (AMR) is a major worldwide issue with serious 
consequences and has been described as ‘one of the greatest health threats 
faced today’ (Davies et al. 2011). AMR has many negative impacts on the health 
and welfare of humans and animals including increased morbidity and mortality 
as well as prolonged illness and may result in treatments being expensive, 
difficult or ineffective (Friedman et al. 2015). The problems are so severe that the 
United Nations General Assembly along with world leaders in the G7 and the 
G20 have stated that AMR is a global crisis (Bloom et al. 2017). The 21st century 
has been described as a post-antibiotic era in which common infections could 
cause death and a global action plan of interventions is needed to mitigate AMR 
(WHO report, 2014). The magnitude of the problem is still not entirely known and 
therefore further research is required into the complex challenge. If current trends 
continue, the rates of morbidity and mortality from infections caused by AMR 
bacteria will increase (deKraker et al. 2016). Understanding the threat of AMR 
will not only help preserve antimicrobials but will also enable the development of 
new antimicrobials or alternative approaches to control infections (Prescott & 
Boerlin, 2016).  
The problem associated with AMR are that resistance to new antibiotics arises 
sooner or later and there is a lack of development of new antimicrobials (Ferri et 
al. 2015). The current dearth of new antimicrobial drug development by the 
pharmaceutical industry can be attributed to reduced economic incentives and 
challenging regulations and polices (Ventola et al. 2015). Furthermore, the lack 
of research and development of novel antimicrobials could be due to a certain 
amount of discouragement due to the fact that new molecules may quickly 
become resistant and therefore ineffective in a short period and that it is not 
always financially viable to develop new antimicrobials (Ferri et al. 2015). 
Antimicrobials have been used to treat infections for decades but have been 
misused in human health care as well as in veterinary care, causing them to 
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become increasingly ineffective. AMR will have serious consequences and it has 
been estimated that by 2050, 10 million people will die every year due to AMR 
unless the issue is taken seriously (de Kraker et al. 2016).  
As well as having severe impacts on human and animal health, AMR also has an 
economic burden and has led to increasing costs in healthcare and could even 
potentially lead to the destabilisation of health systems (Ferri et al. 2015). Health 
care costs are often increased for patients suffering with AMR infections as a 
longer recovery may be required and more expensive drugs may need to be used 
(Ferri et al. 2015). It has been estimated that there will be a reduction of 3% in 
the world gross domestic product (GDP) by 2050 if an effective global AMR 
strategy is not implemented (Sirijatuphat et al. 2017).  
AMR will also have an impact on the livestock industry as it may become more 
difficult to treat resistant infections in livestock, which could create an economic 
burden on livestock producers and may increase prices for consumers. In 
veterinary medicine, antimicrobials are crucial to maintain animal health, animal 
welfare and food safety (Magouras et al. 2017).  AMR is linked between human 
populations, animal populations and the environment, and it is possible for 
resistance to be passed between these populations (Woolhouse et al. 2015). To 
enable a better understanding of the role antimicrobials play in human and 
veterinary medicine it is important to monitor antimicrobial usage in food-
producing animals (Hockenhull et al. 2017). Widespread antimicrobial usage in 
agriculture may contribute to the development of resistance in humans especially 
as there is an overlap of antibiotics used in humans and in food-producing 
animals (Tang et al. 2017). Research has suggested that bacteria in animals that 
are treated with antibiotics can develop resistance and that bacteria carrying 
resistance genes can be transmitted from animals to humans (Tang et al. 2017; 
Liu et al. 2018). Some research has indicated that food-producing animals act as 
reservoirs of resistance genes which could potentially be transmitted to humans 
through the food chain, via direct contact or through the environment, however 
the extent of this transmission is currently unknown (Zurfluh et al. 2015; 
Magouras et al. 2017). Antimicrobials have been inappropriately used in the 
livestock industry; for example, in the pig industry antimicrobials were used for 
the treatment and prevention of disease as well as for other benefits such as 
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growth promotion and feed conversion efficiency, however, attempts have been 
made to limit the inappropriate use of antimicrobials in the livestock industry 
(Stevens et al. 2007).  Strategies need to be developed to reduce AMR in 
humans and animals and these approaches need to be coordinated at national 
and international levels. The evidence suggests that there isn’t a single solution 
to this problem and therefore several approaches need to be taken synergistically 
(Holmes et al. 2016).  
  
Antimicrobials, however, are vital to treat infections in companion animals, 
livestock animals and humans. It is therefore important to fully understand 
potential risk factors associated with transmission of AMR in an attempt to identify 
ways to reduce its severity for farming, global food security, animal welfare and 
both human and veterinary medicine.  
 
1.2 Development of Antimicrobial Resistance  
 
AMR is believed to be a natural phenomenon that is accelerated by selection 
pressure from the use and misuse of antimicrobials in humans and animals 
(WHO, 2014; Wedley et al. 2011). Multidrug resistance is when a bacterium has 
resistance to three or more classes of antimicrobials (Wedley et al. 2017). The 
lack of new antimicrobials to replace ineffective ones means that the existing 
drugs need to be protected (WHO 2014). Resistance can be acquired via 
mutation of chromosomal DNA or by horizontal transfer of resistance via 
transmissible elements called plasmids (Wedley et al. 2011). Bacteria are able 
to respond to the environmental threat of antimicrobial molecules with two genetic 
strategies which both result in resistance: mutations in the genes and horizontal 
gene transfer (Munita & Arias 2016).  
 
1.2.1. Mutational Resistance 
 
Bacteria can acquire resistance to an antimicrobial through mutation and a 
Darwinian selection process which arose to evade destruction from many toxic 
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substances (Holmes et al. 2016). Resistance can arise when an antimicrobial 
attacks a bacterial cell; those that are susceptible die, however those that do not 
succumb survive and replicate in the presence of the antimicrobial and the 
emergence of this resistant phenotype will spread (Giedraitienė et al. 2011; 
Munita & Arias 2016). Most antimicrobials are naturally derived from 
microorganisms such as environmental fungi and saprophytic bacteria or are 
synthetic modifications of these; only a small number are wholly synthetic and 
therefore bacteria have evolved mechanisms to protect themselves from 
antimicrobials (Holmes et al. 2016). Once there is a mutation that makes the 
bacteria resistant and once under selective pressure, the susceptible population 
without the mutation are killed and the bacteria that are newly resistant survive 
and grow (Tenover 2006; Munita & Arias 2016). There are a number of different 
ways that mutations may cause resistance, this could be by altering the target 
protein the antimicrobial molecule binds to, by removing or modifying the binding 
site or by upregulating the production of enzymes that inactivate the antimicrobial 
as well as a number of other ways (Tenover 2006).  
 
1.2.2. Horizontal gene transfer  
 
The second type of antimicrobial resistance is horizontal gene transfer which is 
the acquisition of new genetic material from resistant organisms or the transfer 
of resistance genes from one bacterium to another (Giedraitienė et al. 2011; 
Tenover 2006; Munita & Arias 2016). Horizontal gene transfer is the acquisition 
of genes from another source (usually bacteria) and can be between the same 
species or between different species of bacteria (Tenover 2006; Munita & Arias 
2016).   
 
There are three methods for bacteria to acquire external genetic material: via 
transformation, transduction or conjugation (Bennett et al. 2008). During 
transformation the bacterial cell takes up ‘naked’ DNA (which could have 
resistance genes) from its environment and integrates the DNA into its own 
genome (Bennett et al. 2004). Bacterial transformation is usually from the same 
or closely related species due to self-DNA recognition (Bennett et al. 2004). 
Resistance genes can also be transferred by bacterial viruses (bacteriophages) 
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during transduction (Bennett et al. 2004). Conjugation requires mobile genetic 
elements such as plasmids and transposons which encode a ‘DNA transfer 
system that has evolved specifically to mediate horizontal transfer of itself’ 
(Munita & Arias 2016; Bennett et al. 2004). Plasmids are circular, double-
stranded DNA molecules and generally exist separately and independently of the 
main bacterial chromosome. They do not usually carry core genes needed for 
basic cell growth and multiplication but instead carry accessory genes that may 
be useful periodically to enable bacteria to exploit a particular environmental 
situation, for example, surviving in the presence of potentially lethal 
antimicrobials (Bennett et al. 2008). Resistance plasmids carry a variety of 
different genes (e.g. those that confer antibiotic resistance and resistance to 
some toxic heavy metals). A resistance plasmid is any plasmid that carries one 
or more AMR genes (Bennett et al. 2008). Plasmids have been shown to encode 
genes that confer resistance to different classes of antimicrobials including 
cephalosporins, fluoroquinolones and aminoglycosides (Giedraitienė et al. 
2011).  Resistance transposons are mobile genetic elements that can change 
their position within a genome. These can incorporate a resistance gene within 
the element giving the resistance gene the ability to move within a DNA molecule 
or from one DNA molecule to another (e.g. from one plasmid to another; Bennett 
et al. 2008). 
 
There are different types of biochemical mechanisms that bacteria use to defend 
against antimicrobial molecules these include; decreased uptake, enzymatic 
modification and degradation, altered binding proteins, increased efflux, altered 
target sites and the overproduction of enzymes (Giedraitienė et al. 2011). b-
lactamases are enzymes produced by Gram negative bacteria and are coded on 
chromosomes and plasmids and they are able to hydrolyse many b-lactam 
antimicrobials (e.g. cephalosporins; Giedraitienė et al. 2011).  
 
Bacteria producing extended-spectrum-b-lactamase (ESBL) enzymes are able 
to survive in the presence of various b-lactam antibiotics including a wide range 
of clinically useful medicines (penicillins, cephalosporins, etc.; Leonard et al. 
2017, Giedraitienė et al. 2011). Plasmids carrying ESBLs can move between 
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bacteria and often encode multidrug resistance to antimicrobials including 
quinolones, aminoglycosides and tetracyclines (Leonard et al. 2017). ESBL-
producing Enterobacteriaceae have been identified by the World Health 
Organisation (WHO) as being of ‘critical priority’ for research and for the 
development of new antibiotics active against this group of bacteria (WHO, 
2017). Resistance can be mediated by the acquisition of plasmid-mediated 
ESBLs which hydrolyse and inactivate antimicrobials. Some E. coli strains 
develop resistance to third generation cephalosporins through the acquisition of 
ESBLs through mutations of TEM-, SHV- or CTX-M type enzymes (Tenover 
2006; Zurfluh et al. 2015). Mobile b-lactamase enzymes are given a three letter 
name (e.g. TEM). In 1988 a publication detailed the detection of ESBL genes in 
isolates obtained from pet dogs and other studies have reported the presence of 
the bla genes in isolates obtained dogs, especially those from a clinical origin 
(Carvalho et al. 2016). 
CTX-Ms are b-lactamase enzymes that belong to a class of ESBLs. The spread 
of these enzymes has been referred to as the ‘CTX-M pandemic’ because of the 
increasing penetrance of these b-lactamase genes (bla) across the world 
(Cantón et al. 2012). The origin of CTX-Ms was mobilisation of chromosomal 
blaCTX-M genes from Kluyvera species into mobile genetic elements such as 
transposons and plasmids (Zurfluh et al. 2015; Cantón et al. 2012). CTX-M 
enzymes can be classified by amino acid similarities into five main groups 
(members of the same group share over 94% identity): CTX-M-1, CTX-M-2, CTX-
M-8, CTX-M-9 and CTX-M-25 (Bonnet, 2004). CTX-M genes are found in E. coli 
in the environment as well as many different animals including humans, dogs, 
chickens and other animals. CTX-M-15 is described as ‘by far one of the most 
important’ CTX-M enzymes as it nearly invades all human and animal 
compartments as well as environments all over the world and has been estimated 
to be present in 4% of total ESBL-producing E. coli (Cantón et al. 2012). CTX-M-
1 is the most common ESBL type found in livestock and the second most frequent 
variant associated with human clinical isolates in some countries including 
France and Italy (Kjeldsen et al. 2015).  
TEM-type ESBLs were first reported from an E. coli isolate in 1965 and are 
capable of hydrolysing penicillins and first generation cephalosporins (Shaik et 
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al. 2014). Since 2002, the blaTEM has been detected clinically obtained E. coli 
isolated from dogs (Carvalho et al. 2016).  
OXA-type b-lactamases are named because of their oxacillin-hydrolysing abilities 
and are found in many Gram negative bacteria (Shaik et al. 2014). The most 
common type is OXA-1 which is reported to have been found in 1-10% of 
clinically obtained human E. coli isolates (Shaik et al. 2014). 
AmpC b-lactamase is a bacterial enzyme that is able to destroy antimicrobials 
such as penicillin and is a major clinical concern (Jacoby 2009). Resistance 
through the overexpression of this enzyme in Gram negative bacteria occurs 
usually because of deregulation of the ampC chromosomal gene or by 
acquisition of a mobile genetic element (i.e. plasmid) with a transferable ampC 
gene. This is commonly referred to as a plasmid-mediated AmpC b-lactamase 
(Pérez-Pérez et al. 2002).  
 
The emergence of ESBLs and AmpC-producing E. coli are particularly 
concerning as these bacteria are resistant to a variety of b-lactam antimicrobials 
including highest priority critically important antimicrobials such as third 
generation cephalosporins (Schmidt et al. 2015). ESBL and AmpC-producing E. 
coli have been found worldwide in isolates obtained from humans, food-
producing animals, companion animals and the environment (Hordijk et al. 2013). 
ESBL and AmpC-producing E. coli have been found in both healthy and ill dogs 
and an association has been found between the use of antimicrobials in dogs 
and veterinary healthcare with increased detection of AMR in dogs (Schmidt et 
al. 2015; Damborg et al. 2009).  
 
CMY enzymes are plasmid-mediated b-lactamases found in Gram negative 
bacteria worldwide and can confer carbapenem resistance (Pavez et al. 2008). 
They are thought to have descended from chromosomal ampC genes from 
Citrobacter freundii and Aeromonas spp. (Naseer et al. 2009). CARB-type 





1.3 E. coli  
 
Escherichia coli (E. coli) is a Gram negative bacillus of the Enterobacteriacae 
family. E. coli is a facultative aerobe and is commonly found in the gut of animals 
making it a useful marker for exploring AMR in animals (Blount 2015). E. coli can 
also be easily obtained via faecal samples (Wedley et al. 2011). Many E. coli 
found inhabiting the intestines of animals are harmless commensals, however 
some types cause intestinal and extra-intestinal infections which may require 
antibiotic treatment (Leonard et al. 2017; Timofte et al. 2016). E. coli are found 
in many different animal systems and therefore resistance can be compared in 
different animals; possible transmission between companion animals and 
humans as well as other animals can also be compared (Murphy et al. 2009). 
E. coli has become resistant to antimicrobials through a number of mechanisms. 
These include the overproduction of the target enzyme, modification of antibiotic 
targets, degradation of the antimicrobial agent as well as other mechanisms (van 
Hoek et al. 2011). E. coli can become AMR by chromosomal DNA mutations and 
also as a result of the acquisition of new genetic material through horizontal gene 
transfer (van Hoek et al. 2011). Through horizontal gene transfer, E. coli take up 
DNA with AMR genes (i.e. plasmids) via transformation, transduction or 
conjugation (Burmeister 2015).  
Resistant E. coli is a threat as some E. coli may be opportunist pathogens and 
may be a reservoir of AMR genes for pathogenic or zoonotic bacteria (Murphy et 
al. 2009). E. coli is the most frequent cause of community and hospital-acquired 
urinary tract infections and therefore is a substantial threat to human health 
(WHO report, 2014).  
 
1.4  Antimicrobial usage in small animals 
 
Evidence suggests that use of antibiotics creates a selection pressure that 
contributes to increased AMR, therefore it is imperative to investigate the usage 
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of antibiotics in small animals. In Europe, the prescribing of antimicrobials for use 
in animals must be done by a veterinarian and the prescription data for 
antimicrobials is kept at veterinary practice level; as in human medicine, it is 
therefore very desirable for researchers to collate this data (Radford et al. 2011). 
A study that evaluated data from small animal antimicrobial prescribing patterns 
in the UK revealed that only a small proportion of investigated veterinary 
practices followed antimicrobial use guidelines and suggested that the use of 
guidelines in the UK could reduce antimicrobial use (Hughes et al. 2012). 
Recent research examining 374 veterinary practices in the UK involving nearly 1 
million dogs and 600,000 cats looked at the antimicrobial usage in small animals 
(Prescott & Boerlin, 2016). It estimated that during the 2 years investigated, 
approximately 25% of dogs and 21% of cats registered at the practices received 
at least one course of antibiotics (Prescott & Boerlin, 2016). Of all dog 
antimicrobial usage, 60% was antimicrobials classified as ‘critically important’ for 
human medicine using the WHO criteria (Prescott & Boerlin, 2016). Research 
has suggested that despite the quantity of antimicrobials for veterinary use sold 
in the UK decreasing since 2002, the total sales of antimicrobials for non-food-
producing animals has increased, especially for usage in dogs (Wedley et al. 
2011). This increase in use and resultant selection pressures may have a knock-
on effect of higher carriage of AMR in small animals (Wedley et al. 2011). The 
high levels of antimicrobial usage in small animals in the UK also indicates that it 
is important to research AMR in these species and to investigate possible 
interventions to reduce the impact of AMR. There are concerns that the use of 
antimicrobials in animals may contribute to resistance in humans which has led 
to the suggestion that the use of quinolones and cephalosporins should be 
restricted in animals (Radford et al. 2011).  
 
1.5 Dog acquisition of antimicrobial-resistant bacteria 
 
There are a number of ways that dogs may acquire AMR E. coli. Some evidence 
has suggested that animals can acquire resistance from the environment; 
acquisition through the natural environment has been recognised as a possible 
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transmission route but has been understudied (Leonard et al. 2017). Manure is 
often used as a fertiliser for crops, and wastewater from run-off which enters 
waterways may introduce bacteria with diverse mobile genetic elements to 
coastal waters alongside compounds that select for resistant microorganisms 
(Leonard et al 2017; Amos et al. 2014). Studies have shown that ingestion of 
water containing AMR E. coli is associated with gut colonisation by these bacteria 
(Coleman et al. 2012). The ingestion of resistant E. coli that then colonises the 
gut of the dog may be a possible route of acquisition of resistant bacteria. 
Research has also suggested that dogs acquire AMR bacteria when visiting 
veterinary hospitals which have been shown to act as a reservoir for multi-drug 
resistant organisms (Gibson et al. 2011; Ogeer-Gyles et al. 2006; Hutton 2018). 
The risk of acquiring AMR bacteria from veterinary hospitals could be due to the 
fact that patients are often susceptible to infection as well as the high selection 
pressure for resistance due to antibiotic use within practices (Hutton 2018). 
Studies have concluded that the use of antimicrobial agents selects for and 
promotes the transfer of AMR. Furthermore, antimicrobials are frequently 
prescribed to dogs and there is evidence of development of resistance in 
response to treatment (Singleton et al. 2017; Gibson et al. 2011; Ogeer-Gyles et 
al. 2006; Trott et al. 2004). The close domestic relationship between dogs and 
their owners has also raised the concern that resistant bacteria could be 
transmitted between the species (Hutton 2018).  
 
1.6 Antimicrobial resistance in dogs 
 
A study that investigated dogs visiting a UK veterinarian practice found that many 
of the dogs sampled had AMR E. coli (44.8% of 260 dogs; Wedley et al. 2017). 
The aim of that particular study was to estimate the prevalence and investigate 
the molecular characteristics of ESBL and plasmid-encoded AmpC-producing E. 
coli in the UK vet-visiting canine population (Wedley et al. 2017). The authors 
provided owners with questionnaires to enable identification of potential factors 
associated with AMR carriage and used faecal samples obtained from the dogs 
to identify resistant E. coli. They found that recent use of antimicrobials and dogs 
being fed raw poultry were risk factors for AMR (Wedley et al. 2017). 
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Research has also been conducted on E. coli isolated from clinical samples from 
dogs to determine AMR. Normand and colleagues explored data from 1989-1997 
and found a significant increase in individual resistance of E. coli carried by dogs 
to amoxicillin-clavulanate and streptomycin (2000). These studies provide 
evidence for understanding resistance, however it is also critical to examine 
healthy dog populations to fully understand the carriage of AMR in dogs. 
Research into the prevalence of faecal carriage of ESBL/AmpC-producing E. coli 
in healthy companion animals is limited (Hordijk et al. 2013), although there are 
at least two studies investigating faecal samples from healthy dogs to determine 
the carriage of AMR E. coli. Studies have investigated faecal samples from 
healthy dogs to determine the carriage of E. coli that have AMR. A study of 78 
dogs in Portugal looked at possible risk factors associated with AMR and found 
that previous quinolone treatment and coprophagic habits were risk factors 
associated with the increased carriage of AMR bacteria (Leite-Martins et al. 
2014). Another study showed that dogs are carriers of AMR E. coli; 183 healthy 
dogs in Cheshire were examined and 29% carried resistant isolates (Wedley et 
al. 2011). These studies indicate that adult dogs are carriers of resistant E. coli.  
 
Dogs that are given antibiotic treatment have also been shown to carry an 
increased amount of resistant bacteria. The effect of oral amoxicillin treatment on 
seven healthy adult dogs was evaluated by looking at the faecal microbiota of 
the dogs (Grønvold et al. 2010). The prevalence of bacterial resistance and 
changes to the bacterial population were examined. After four to seven days of 
exposure to amoxicillin the faecal E. coli expressed resistance to multiple 
antibiotics compared to before the exposure to amoxicillin (Grønvold et al. 2010). 
This indicates the impact antibiotics can have on AMR in dogs and is more 
evidence that recent antibiotic treatment is a risk factor for the carriage of AMR 
E. coli by dogs. Overall, AMR bacteria have been detected in both healthy and 
sick adult dogs, associations have been found between increased AMR and 
exposure to antimicrobials and veterinary healthcare as well as with coprophagia 
and dogs being fed raw poultry (Wedley et al. 2017; Grønvold et al. 2010; Leite-




1.7 Aims and Objectives  
 
In this study, different risk factors were investigated to explore associations 
between various lifestyle factors and the detection of resistant E. coli in puppy 
faecal samples. It was hypothesised that there are certain factors in the 
management and lives of puppies and dogs that increase or decrease the risk of 
carriage of AMR E. coli.  
It was postulated that a dog’s diet would be a potential risk factor and that the 
feeding of raw meat would increase the risk of resistant E. coli in the gut of the 
puppy or dog, as has been shown previously. Baede and colleagues suggested 
a possible association between AMR in faecal E. coli of dogs that were fed raw 
meat (2015) and Schmidt and colleagues isolated faecal E. coli from healthy 
Labradors in the UK and also found raw feeding dogs to be a risk factor and a 
potential source of AMR transmission (Schmidt et al. 2015). 
Further hypotheses investigated in this study were that the environment in which 
the dog is walked would be associated with carriage of resistant E. coli. The 
impacts of puppies and dog walking in different environments such as 
countryside, town, farmland, beaches and near cattle were explored to see 
whether walking in these environments increased the risk of the dog carrying 
resistant E. coli. 
Another hypothesis was that the puppy swimming and playing in water would 
increase the risk of carriage of AMR E. coli. Playing in saltwater, lake water, river 
water and pond water was investigated to assess whether there was a correlation 
between the dog swimming in these water sources and having resistant E. coli.  
It was also postulated that rolling in cow pats or fox faeces would increase the 
risk of the dog carrying AMR E. coli and that dogs displaying autocoprophagic 
behaviours would be at a greater risk of having resistant bacteria.  
This research also assessed whether the age of the dog had an impact on the 
carriage of resistant E. coli and compared resistance in 12-week-old puppies, 16-
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week-old puppies and adult dogs. It was hypothesised that as the dog ages, the 
risk of carrying resistant E. coli would increase as the dog is exposed to more 
resistance in the environment. It was also possible to compare 16-week-old 
puppies recruited from different areas in the UK to assess any difference in 
resistance. It was postulated that any differences in recruitment locations would 
























Chapter 2 - Materials and Methods 
 
2.1 Recruitment of the cohorts 
 
Puppy and adult dog owners were recruited to take part in this study, with puppy 
owners recruited in two ways: (1) 236 were already recruited to the Generation 
Pup project, a longitudinal study looking at the health, welfare and behaviour of 
dogs across the UK and (2) 80 recruited via word-of-mouth advertisement to 
clients bringing puppies in for routine checks to veterinary practices in Somerset, 
North Somerset, Bath and Bristol. As part of Generation Pup, owners completed 
surveys relating to their puppies at 16 weeks of age. Data provided in answer to 
questions set out in the Appendix were extracted from the wider Generation Pup 
survey data. Puppy owners also supplied a single faecal sample at 16 weeks of 
age. Local puppies were recruited via puppy socialisation classes, social media 
and local media advertisement. Here, owners answered survey questions as set 
out in the Appendix in relation to puppies aged ≤12 weeks and again at 16 weeks. 
Local owners provided two faecal samples for each puppy: one at ≤12 weeks 
and one at 16 weeks of age. All puppy owners were recruited between August 
2017 and March 2018 and all owners gave consent. Ethical approval for this 
study was granted by the University of Bristol Health Sciences Student Research 
Ethics Committee (56783). Health status of the puppies and prior veterinary 
treatment was not recorded. However, puppies that had been previously 
hospitalised were excluded. 
Adult dogs were also recruited in two ways: (1) 18 adult dogs were recruited from 
veterinary practices and by word of mouth in Somerset, North Somerset, Bath 
and Bristol between October 2017 and January 2018. These adult dog owners 
were asked to complete a questionnaire (Appendix) and asked to provide a faecal 
sample from their dog. (2) 16 adult dogs were recruited from the River Thames 
area of Bullcroft Park, Wallingford, Oxfordshire in November 2017. These adult 
dog owners were asked to provide a faecal sample collected from their dog.  
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2.2 Faecal samples and processing 
 
On recruitment, puppy and dog owners were supplied with a sample collection 
pack comprised of a specimen bottle, gloves, biohazard bag and a free post 
envelope. For those owners asked to provide a second sample (local puppy 
owners), another sample collection pack was sent to them by post. Owners of 
these locally recruited puppies were asked to provide fresh faecal samples as 
follows: the first sample before their puppy was walked in public areas and the 
second sample when the puppy was over 16-weeks-old and able to walk in public 
areas. The locally recruited and Oxfordshire adult dogs were asked to provide 
one faecal sample from their dog. Faecal samples were then sent by post to the 
University of Bristol’s Veterinary School alongside the consent form and 
questionnaire. To process each faecal sample, approximately 0.1-0.5 g of the 
faecal samples was taken and weighed. 10 ml per g of phosphate buffered saline 
(PBS) was added to the sample and the mixture vortexed. Next, 0.5 ml of the 
faecal/PBS homogenate was added to 0.5 ml of 50% v/v glycerol, and samples 
were archived at -70°C. All faecal samples were treated in the same way.  
 
2.3 Testing for antimicrobial resistance 
 
To test for AMR in the E. coli of the faecal samples, each faecal homogenate was 
plated on six different Tryptone Bile X-Glucuronic Agar (TBX) agar plates. These 
were TBX containing no antibiotics or TBX containing either ciprofloxacin, 
cephalexin, amoxicillin, tetracycline or streptomycin. Onto each of these six 
plates, 20 µl of the faecal homogenate was spread. The breakpoints were: 
ciprofloxacin 0.5mg/L, tetracycline 16mg/L, amoxicillin 8mg/L, cephalexin 
16mg/L, streptomycin 64mg/L (European Committee on Antimicrobial 
Susceptibility Testing 2018). It was necessary to use 10-fold serial dilution on 
some of the faecal homogenates with PBS to achieve countable numbers of 
colonies. The plates were incubated at 37°C overnight. The number of green/blue 
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E. coli colonies on each plate were counted and recorded in a database.  
2.4 Levels of detection 
 
Some puppy and adult dog faecal samples were excluded from this study as no 
E. coli were found on the plates containing no antibiotics and therefore it could 
not be determined whether there was resistant E. coli  or not. A limit of detection 
was chosen whereby only samples where 20 or more colonies grew on agar (with 
no antibiotics) were retained in the analysis thereby ensuring an appropriate level 
of detection. Samples with a count of less than 20 cfu (colony-forming-units) on 
agar with no antibiotics (when 1 µg of faeces was plated) were re-plated using a 
larger inoculum of 5 µg (100 µl of the faecal homogenate) to test for resistance 
at a higher volume. If the E. coli count was less than 20 cfu with this larger 
inoculum, the samples were excluded from this study.  
 
2.5 Risk factor analysis  
 
A risk factor analysis was carried out on the data from 12-week-old puppies 
(locally recruited), 16-week-old puppies (locally recruited and Generation Pup) 
and adult dogs (locally recruited). The risk factor analysis was done with advice 
from Ashley Hammond who coded and provided the original models. The faecal 
samples were coded as being positive or negative for E. coli resistant to any 
antibiotic as well as positive or negative to each of the five antibiotics: 
ciprofloxacin, cephalexin, amoxicillin, tetracycline and streptomycin. 
Questionnaire data from the locally recruited dog and puppy owners along with 
relevant data extracted from the wider Generation Pup surveys was used in the 
risk factor analysis.  
Univariable and multivariable logistic regression models were used to evaluate 
associations between resistance and risk factors identified from the survey data 
(Stata/IC 15.1, StataCorp LLC, College Station, TX, USA). A backward stepwise 
method was used. In this method the full set of possible factors were analysed, 
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with the least significant factors removed one-at-a-time until all remaining factors 
had p-values of 0.05 or less. Multivariable models were carried out on all of the 
screened 16-week-old puppy samples (n=223), however autocoprophagia, 
rolling in cow pats and rolling in fox faeces were excluded as these were only 
present in the Generation Pup data. Therefore, multivariable models were also 
built for the Generation Pup data alone (n=182) which could include 
autocoprophagia, rolling in cow pats and rolling in fox faeces as predictors.  
Risk factor associations were considered statistically significant if p<0.05. For the 
risk factor analysis, it was necessary to categorise questionnaire answers as 
‘Yes’ or ‘No’; questionnaire answers of ‘sometimes, often, almost always, and 
frequently’ were all categorised as ‘Yes’. Some categories were combined as part 
of the analysis.   
The risk factors investigated were: feeding the puppy uncooked/raw food, 
walking the puppy in town/city, walking the puppy on farmland, walking the puppy 
on beaches, walking the puppy in the countryside, walking the puppy around 
cattle, whether the puppy had ever swum/paddled/played in salt water, whether 
the puppy had ever swum/paddled/played in lake water, whether the puppy had 
ever swum/paddled/played in river water, whether the puppy had ever 
swum/paddled/played in pond water, whether the puppy had ever rolled in cow 
pats, whether the puppy had ever rolled in fox faeces and if the puppy had 
displayed autocoprophagic behaviour in the past seven days. 
 
2.6 Statistical Tests 
 
Other statistical tests were also carried out. Pearson’s chi-squared test was used 
to calculate the p-values for the baseline data from the locally recruited adult 
dogs comparing whether AMR was found in E. coli obtained from the faecal 
samples depending on whether the questionnaire response was ‘Yes’ or ‘No’ 
using Stata (Table 3.2). A p-value below 0.05 was considered significant. Fisher’s 
Exact Test was used to compare whether or not resistance to each of the 
antimicrobials was found in the E. coli obtained from locally recruited 12-week-
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old puppies and 16-week-old puppies and to compare whether resistance to each 
of the antimicrobials was or was not found in the E. coli in puppies recruited 
locally and puppies recruited through Generation Pup (Table 3.4 and Table 3.5). 
A p-value was considered significant if below 0.05. 
 
2.7 Molecular Techniques – PCR, Whole Genome Sequencing 
 
The 12-week-old puppy, 16-week-old puppy and adult dog samples that grew E. 
coli with resistance to cephalexin and ciprofloxacin underwent molecular 
procedures to provide polymerase chain reaction (PCR) and whole genome 
sequence data (Figure 2.1; Figure 2.2). These techniques were carried out by 
Jacqueline Findlay and Oliver Mounsey.  
Polymerase chain reaction (PCR) is rapid technique used in molecular biology 
that allows the precise detection and production of large amounts of DNA and is 
extensively used by both researchers and clinicians to diagnose diseases, clone 
and sequence genes (Garibyan & Avashia 2013). The requirements for a PCR 
are template DNA, primers, nucleotides and DNA polymerase. Taq DNA 
polymerase is an enzyme isolated from Thermus aquaticus that joins individual 
nucleotides together to form the PCR product (Saiki et al. 1988; Garibyan & 














Figure 2.1. Flow diagram showing the sequence of events of processing the 
faecal samples, screening for cephalexin resistance, re-screening for cefotaxime 
resistance and further molecular testing (PCR and whole genome sequencing).    
 
16-week-old puppy faecal samples were processed. 
 16-week-old puppy faecal samples plated on 6 different TBX agars (non-antibiotic agar, 
agar containing ciprofloxacin, cephalexin, streptomycin, tetracycline or amoxicillin). 
 
Some of the 16-week-old puppy sample plates grew green/blue colonies on cephalexin 
TBX agar. This indicated resistance to cephalexin. 
 
Plates with cephalexin-resistant E. coli were sent to Jacqueline Findlay for further tests. 
 
Five E. coli colonies from each cephalexin plate were plated onto TBX agar containing 
cefotaxime. This was to test for cefotaxime (3rd generation cephalosporin) resistance. 
 
 E. coli from the 16-week-old puppy samples where cefotaxime-resistance was detected 
were then sent for PCR. 
The cefotaxime-resistant E. coli obtained from the 16-week-old puppy samples were also 












Figure 2.2. Flow diagram showing the sequence of events of processing the 
faecal samples, screening for ciprofloxacin resistance and further molecular 
testing (PCR and whole genome sequencing).   
16-week-old puppy faecal samples were processed. 
 16-week-old puppy faecal samples plated on 6 different TBX agars (non-antibiotic agar, 
agar containing ciprofloxacin, cephalexin, streptomycin, tetracycline or amoxicillin. 
 
Some of the 16-week-old puppy sample plates grew green/blue colonies on ciprofloxacin 
TBX agar. This indicated resistance to ciprofloxacin. 
 
Plates with ciprofloxacin-resistant E. coli were sent to Jacqueline Findlay for further tests. 
 
Five E. coli colonies from each ciprofloxacin plate were re-plated onto TBX agar again 
containing ciprofloxacin.  
 
 E. coli from the 16-week-old puppy samples where ciprofloxacin resistance was detected 
were then sent for PCR. 
The ciprofloxacin-resistant E. coli obtained from the 16-week-old puppy samples were also 
sent off for whole genome sequencing. 
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Five E. coli colonies from the cephalexin were re-plated by Jacqueline Findlay 
onto TBX agar containing cefotaxime (third generation cephalosporin) in order to 
select for b-lactamases, ESBLs and for AmpC production and were incubated 
overnight at 37oC.  
Molecular tests were carried out on the cefotaxime and ciprofloxacin resistant E. 
coli. BL, CTX-M and Random Amplification of Polymorphic DNA (RAPD) PCRs 
were carried out. The CTX-M as well as other BL multiplexes (TEM, SHV, CMY, 
DHA, OXA-1) and floR primers were performed on the cefotaxime-resistant 
colonies. First lysates were prepared by boiling 1-2 colonies in 100 µl of water for 
5 minutes at 95oC in the thermal cycler. The plates were then centrifuged at 3500 
rpm for 5 minutes and 1 µl of lysate per PCR rxm were used. The conditions used 
for the CTX-M and RAPD PCR are shown for CTX-M multiplex (Table 2.1; Table 
2.3); an annealing temperature of 62oC was required whereas for BL an 
annealing temperature of 56oC was required (Table 2.2).  
 
Table 2.1. Primers for the CTX-M multiplex PCR. The primer name, sequence 
and product size are shown. 62oC annealing was required.  
Primer Sequence (5’-3’) Product size 
(bp) 
Group1_F AAAAATCACTGCGCCAGTTC 415 
Group1_R AGCTTATTCATCGCCACGTT 
Group2_F CGACGCTACCCCTGCTATT 552 
Group2_R CCAGCGTCAGATTTTTCAGG 
Group9_F CAAAGAGAGTGCAACGGATG 205 
Group9_R ATTGGAAAGCGTTCATCACC 
Group8_F TCGCGTTAAGCGGATGATGC 666 
Group25_F GCACGATGACATTCGGG  




Table 2.2. Primers for the BL multiplex PCR. The primer name, sequence and 
product size are shown. 56oC annealing was required.  
Primer Sequence (5’-3’) Product size (bp) 
CMY_G1_F CGATCCGGTCACGAAATACT 556 
CMY_G1_R CCAGCCTAATCCCTGGTACA 
DHA_F GTGAAATCCGCCTCAAAAGA 341 
DHA_R ACAATCGCCACCTGTTTTTC 
TEM_F CCGAAGAACGTTTTCCAATG 249 
TEM_R GTCCTCCGATCGTTGTCAGAA 
SHV_F CTTTCCCATGATGAGCACCT 127 
SHV_R GCGAGTAGTCCACCAGATCC 
OXA_F TTATCTACAGCAGCGCCAGT 451 
OXA_R AAGCTACTTTCGAGCCATGC 




The PCR set up required 10 µl of MyTaq mix, 0.5/1 µl of Primer mix, 8 µl of water 
and 1 µl of DNA. The cycling conditions were 98oC for initial denaturation with a 
duration of 5 minutes followed by 30 seconds of denaturation at 98oC and then 
annealing at 62oC or at 56oC for 35 cycles of 30 seconds for CTX-M or 30 cycles 
for 30 seconds for BL. An extension period of 30 seconds at 72oC was followed 
by a final extension for 5 minutes at 72oC. The hold conditions were kept at 10oC. 
Controls were also included in each run.  
A RAPD PCR was also carried out on isolates, and a primer was used (Table 
2.3). This PCR set-up used the same volumes as above. The cycling conditions 
were 5-minute initial denaturation at 98oC then 30 seconds denaturation at 98oC. 
This was followed by 45 cycles of 30 seconds at 36oC and then a 30 second 
period of extension at 72oC and a final extension for 5 minutes at 72oC. The hold 
temperature was 10oC. 
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The cefotaxime-resistant E. coli colonies from the puppies and dogs were sent 
off for whole genome sequencing to provide further information about AMR. 
Multilocus sequence typing (MLST) was carried out on the E. coli to provide 
information about the Sequence Type (ST) of the E. coli. The whole genome 
sequence provides data on genome size, ST, MLST genes found as well as the 
resistance genes detected. The virulence genes and plasmids are also identified. 
STs can be identified using the Achtman Scheme 
(http://mlst.warwick.ac.uk/mlst/dbs/Ecoli) to see in which species they commonly 
occur. The whole genome sequencing data is vital in fully understanding the 
origins of E. coli found in the dogs and possible routes of transmission of the 
resistance. The PCR and whole genome sequencing results were returned to me 
and I analysed the results. The ST could be searched on a database called 
EnteroBase to look for other places the ST had been found previously. It was 








Primer Sequence (5’-3’) 
1283 GCGATCCCCA 
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AMR is a rapidly worsening global health threat that impacts the heath of animals 
and humans (Tacconelli et al. 2017). Because many serious bacterial infections 
are opportunistic, the carriage of AMR bacteria in normal flora of dogs is a 
potential source of infections that are difficult to treat in dogs as well as in the 
humans who interact with them (Wedley et al. 2011). E. coli is a bacterium 
commonly found in the intestines of dogs (Carattoli et al. 2005) and previous 
studies have highlighted the high prevalence of AMR E. coli found in faecal 
samples taken from dogs (Hordijk et al. 2013). E. coli is a primary cause of 
opportunistic community- and healthcare-associated infections in humans in the 
UK (Abernethy et al. 2017). Dogs live in close proximity to humans and potentially 
may pass on AMR E. coli to humans and vice versa (Costa et al. 2007; 
Guardabassi et al. 2004; Sidjabat et al. 2006). Studies examining transmission 
of E. coli within a household concluded that some E. coli are transmitted between 
household members, including dogs (Damborg et al. 2009; Johnson et al. 2008; 
Grönthal et al. 2018). It is also possible that dogs carry and spread AMR bacteria 
to other animal species. For instance, if dogs are found to contribute to the 
transmission of AMR to livestock, this could pose a problem for the food industry 
and global food security.  
An increased understanding of the risk factors that lead to colonisation of dogs 
with AMR E. coli may help suggest possible interventions to reduce AMR. The 
use of antimicrobials is already a known risk factor for the acquisition of AMR in 
dogs (Wedley et al. 2011; Schmidt et al. 2015), however, this may not be the only 
driver; management practices that influence ingestion of AMR bacteria may also 
play a key role, particularly in early life. Accordingly, the aim of this study was to 
evaluate the occurrence of AMR E. coli in the faeces of puppies (at 16 weeks of 
age) and to assess potential associations between risk factors from the puppy’s 
lifestyle that may influence the abundance of AMR E. coli. Of particular interest 
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was the influence of environmental interaction on AMR carriage.  
 
3.2 Results and Discussion  
 
Table 3.1. Number of faecal samples and completed surveys for locally recruited 
and Generation Pup (nationally recruited) puppies at ≤12 weeks and 16 weeks 
of age. Samples that had a limit of detection issue where the E. coli count was 










Table 3.1 shows the number of 12-week-old and 16-week-old puppies that were 
recruited for this study through Generation Pup and those that were locally 
recruited. The number of these samples that were screened and included in the 
results are also shown (Table 3.1). In total, 287 puppies were screened as they 
had completed surveys and faecal samples to test for antimicrobial resistant E. 
coli (Table 3.1). There was a surprisingly low amount of E. coli detected in the 
16-week-old puppy faecal samples and a high number of puppy faecal samples 
that did not grow E. coli colonies on the agar plates containing no antibiotics (14 
of the 16-week-old puppy samples were excluded due to incomplete 
questionnaires and 58 were excluded due to limit of detection; Table 3.1).  







Screened 64 - 




Screened 41 182 
Excluded 18 54 
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A total of 223 16-week-old puppies were screened for AMR (Generation Pup and 
locally recruited). The baseline questionnaire data was used to test the 
association of specific responses with the presence of resistance (i.e. to one or 
more of: amoxicillin, cephalexin, ciprofloxacin, streptomycin or tetracycline) in E. 
coli from the faecal sample using the Pearson Chi-squared test (Stata/IC 15.1, 
StataCorp LLC, College Station, TX, USA). A puppy being fed raw food was the 
only risk factor with a high level of significance (Pearson chi-squared 14.41; p-
value 0.001; Table 3.2). Some possible risk factors (autocoprophagia, rolling in 
cow pats and rolling in fox faeces) which looked promising based on initial 
analyses could only be obtained from the Generation Pup data (not the locally 
recruited dogs) because that survey was more extensive. As part of the wider 
Generation Pup survey, the puppy owners were asked whether their 16-week-
old puppy had displayed autocoprophagic behaviour in the past seven days and 
this data was included in the analysis. These data are presented separately 
(Table 3.3). Again, in the Generation Pup data only, puppies being fed raw food 
was a significant risk factor (Pearson chi-squared 9.82; p-value 0.002) and 
puppies displaying autocoprophagic behaviours in the past seven days was 
protective (Pearson chi-squared 6.56; p-value 0.01; Table 3.3) 
 
Table 3.2. Baseline data for all 16-week-old puppies (Generation Pup and locally 
recruited; n=223) and associations with risk factors for AMR. P-values were 
calculated using the Pearson Chi-squared test. The bold figures show a p-value 
< 0.05. 













Fed raw food 
 
Yes 43 32/43 <0.001 
No 180 76/180 
Walked in town 
 
Yes 181 84/181 0.21 
No 42 24/42 
Yes 142 69/142 0.95 
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Yes 103 52/103 0.57 
No 120 56/120 
Walked in the 
countryside 
 
Yes 191 95/191 0.34 




Yes 84 37/70 0.31 
No 139 71/139 
Swum/ paddled/ 
played in salt 
water 
 
Yes 62 32/62 0.56 
No 161 76/161 
Swum/ paddled/ 
played in lake 
water 
 
Yes 29 17/29 0.24 
No 194 91/194 
Swum/ paddled/ 
played in river 
water 
 
Yes 66 33/66 0.76 
No 157 75/157 
Swum/ paddled/ 
played in pond 
water 
 
Yes 65 38/65 0.06 






Table 3.3. Baseline data for 16-week-old puppies recruited through Generation 
Pup (n=182) and associations with risk factors for AMR. P-values were calculated 
using the Pearson Chi-squared test. The bold figures show a p-value < 0.05. 














Fed raw food 
 
Yes 41 30/41 0.002 
No 141 64/141 
Walked in town 
 
Yes 141 70/141 0.32 
No 41 24/41 
Walked on farmland 
 
Yes 119 61/119 0.89 
No 63 33/63 
Walked on beaches 
 
Yes 80 42/80 0.84 
No 102 52/102 
Walked in the 
countryside 
 
Yes 165 86/165 0.69 
No 17 8/17 
Walking near cattle 
 
Yes 68 31/68 0.21 
No 114 63/114 
Swum/ paddled/ 
played in salt water 
 
Yes 50 29/50 0.29 
No 132 65/132 
Swum/ paddled/ 
played in lake water 
 
Yes 26 15/26 0.51 
No 156 79/156 
Swum/ paddled/ 
played in river water 
 
Yes 56 29/56 0.98 
No 126 65/126 
Swum/ paddled/ 
played in pond water 
 
Yes 65 38/65 0.11 
No 124 59/124 
Rolled in cow pats Yes 6 5/6 0.11 
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 No 176 89/176 
Rolled in fox faeces 
 
Yes 9 4/9 0.66 
No 173 90/173 
Displayed 
autocoprophagic 
behaviour in past 
seven days 
 
Yes 15 3/15 0.01 
No 167 91/167 
 
Univariable and multivariable logistic regression analyses were carried out on the 
data from the 16-week-old puppies in order to investigate more deeply the 
potential risk factors identified as being significant or tending to significance in 
the preliminary analysis (Table 3.4). A strong association was demonstrated 
between feeding a 16-week-old puppy raw food and the carriage of E. coli with 
resistance to any of the antibiotics as well as individually with resistance to all 
five of the antibiotics tested (Table 3.4). An example of this association is that 
puppies that were raw food had between 5.01 to 30.78 greater odds of having 
ciprofloxacin-resistant E. coli than puppies that were not raw fed (Multivariable: 
12.42 (5.01 to 30.78) <0.001; Table 3.4).  
This is evidence that puppies that are raw fed have an increased risk of carrying 
AMR E. coli. This link has also been previously reported. A study based of 445 
dogs found that feeding raw poultry significantly increased the risk of carrying 
fluoroquinolone-resistant E. coli in the UK adult dog population (Wedley et al. 
2017). A study of Labradors also found an association between dogs who ate 
raw food and amoxicillin resistance (Schmidt et al. 2015). A study on E. coli from 
faecal samples taken from broilers at a slaughterhouse also detected 
ciprofloxacin resistance which may have been due to the usage of 
fluoroquinolones in the production of broilers (Costa et al. 2009) and this could 
be a potential source of resistance in dogs having been fed raw food. Raw 
chicken imported to the UK has also been identified as a source of 
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fluoroquinolone-resistant E. coli (Warren et al. 2007) and AMR E. coli have been 
found in uncooked chicken carcasses (Randall et al. 2011; Machado et al. 2008). 
The risk of puppies acquiring AMR bacteria from raw food could be mitigated by 
cooking meat in order to reduce contamination and colonisation of the gut with 
such bacteria. It may also be possible that the raw food diet creates a gut 
environment which is selective for AMR E. coli.  
It is also possible that people can acquire AMR bacteria from puppies and some 
have hypothesised that companion animals may act as reservoirs for AMR 
bacteria and may transmit these to humans, hence a One Health approach needs 
to be taken (Ewers et al. 2012; Gandolfi-Decristophoris et al. 2013; Timofte et al. 
2016). Due to the close proximity of dogs to humans and other domestic pets, it 
is feasible that AMR bacteria could be easily transmitted by owners coming into 
contact with faecal matter from their dog. Owners that raw feed their dog may be 
at greater risk through handling raw food contaminated with AMR bacteria, but 
also because AMR bacteria are being shed in the faeces of their raw-fed dog. 
Several studies have promoted the theory that the spread of (clinically relevant) 
multi-resistant ESBL-producing E. coli has a zoonotic potential (e.g. between 
dogs, poultry and humans) and that a One Health approach is needed to prevent 
this (Overdevest et al. 2011; Mora et al. 2010; Schaufler et al. 2015). 
Swimming in lake water was shown to be a potential risk factor for ciprofloxacin 
resistance (Univariable: 3.72 (1.44 to 9.61) 0.007; Table 3.4). Swimming in pond 
water was a potential risk factor for tetracycline resistance (Univariable: 1.80 
(1.00 to 3.25) 0.05; Table 3.4) and amoxicillin resistance (Multivariable: 1.91 
(1.05 to 3.48) 0.04; Table 3.4). Swimming in pond water also showed a trend for 
resistance to any of the antibiotics (Multivariable: 1.66 (0.91 to 3.04) 0.10). It can 
therefore be hypothesised that swimming in water may be a risk factor for 16-
week-old puppies carrying resistant E. coli and further investigation into this 
potential risk factor should be carried out. In Chapter 4 a comparison is made 
between adult dogs recruited from an area close to the River Thames 
(Oxfordshire) to another cohort of dogs recruited around Bristol in order to 
evaluate whether playing in water has an impact on AMR.  
 40 
Some risk factors were only investigated in the 16-week-old puppies recruited via 
Generation Pup (n=182; Table 3.5) as data on these risk factors was not 
available for locally recruited puppies. Puppies that rolled in cowpats (six were 
identified in the Generation Pup cohort) were shown to have an increased risk of 
carrying cephalexin-resistant E. coli (Multivariable: 5.52 (1.06 to 28.79) 0.04; 
Table 3.5) or streptomycin-resistant E. coli (Multivariable: 11.42 (1.51 to 86.17) 
0.02; Table 3.5). A possible explanation for this is that there is a fitness 
advantage for streptomycin-sensitive versus streptomycin-resistant strains to be 
carried in dogs in the absence of selection (Frost et al. 2018). Generally 
interacting with cattle as part of the wider environment may provide for a more 
complex microbiological flora, where competition can occur and resistance may 
be reduced. Rolling in cowpats may predispose dogs towards a more restricted 
flora where competition is less and therefore resistance can thrive. More work is 
needed to investigate this potential risk factor, and research is currently 
underway at the University of Bristol determining the levels of AMR E. coli in 
cattle faeces to find patterns and possible risk factors which may contribute to 
evaluating this risk factor.  
Puppies that displayed autocoprophagic behaviour in the seven days prior to 
sampling had a reduced risk of carrying E. coli with resistance to any one of the 
antibiotics (Generation Pup recruited; Multivariable: 0.22 (0.06 to 0.83) 0.03; 
Table 3.5) as well as reduced risk of specifically carrying tetracycline- and 
amoxicillin-resistant E. coli (Table 3.5). The observation that autocoprophagia 
reduces the risk of puppies and dogs carrying AMR E. coli has not been identified 
previously. At least one other study found that dogs showing coprophagic 
behaviour (eating either their own faces or faeces from other animals such as 
livestock) were at increased risk of carrying AMR bacteria (Leite-Martins et al. 
2014). However, this study only considered adult dogs not puppies and looked 
at both autocoprophagy and allocoprophagy. These differences in populations 
could be an explanation for the difference in the results. It could be postulated 
that autocoprophagy has a different impact on young puppies compared to adult 
dogs due to differences in gut flora however, further research would need to be 
conducted.  
The risk factor analysis generated possible hypotheses which could explain 
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resistance in the E. coli carried by the 16-week-old puppies. Some potential risk 
factors were not significant (>0.05) in the multivariable analyses, however, they 
may reveal trends for further investigation. Walking around town showed a trend 
for ciprofloxacin resistance (Multivariable: 4.66 (0.96 to 22.64) 0.06) in the whole 
dataset but it was significant in the Generation Pup data (Multivariable: 4.83 (1.00 
to 23.39) 0.05; Table 3.5). This could suggest that there is less walking around 
town in the local cohort compared to the Generation Pup cohort. In the 
Generation Pup data, playing in salt water also showed a trend for tetracycline 
resistance (Multivariable: 1.86 (0.93 to 3.73) 0.08). All of these trends require 
further investigation to establish whether they are risk factors for AMR. 
 
Table 3.4. Univariable and multivariable logistic regression analyses using 
questionnaire data and AMR E. coli data for 16-week-old puppies (recruited via 
Generation Pup and locally recruited), excluding samples with a limit of detection 
issue where the E. coli count was less than 20 cfu or missing or incomplete 
questionnaires (n=223). Presentation: Odds ratio (95% confidence interval) p-
value. Only significant risk factors are shown the full results are present in the 
appendix. The bold figures indicate a significant p-value p<0.05.  
Risk Factor Univariable 
(n=223) 
Multivariable for 






Resistance to any antibiotic (n=108) 
Fed raw food 3.98 (1.89 to 
8.40) <0.001 
3.98 (1.89 to 8.40) 
<0.001 
3.20 (1.47 to 
6.96) 0.003 
Resistance to ciprofloxacin (n=26) 
Fed raw food 12.42 (5.01 to 
30.78) <0.001 
12.42 (5.01 to 
30.78) <0.001 




3.06 (0.69 to 
13.48) 0.14 
4.66 (0.96 to 
22.64) 0.06 
4.83 (1.00 to 
23.39) 0.05 
Swum/paddled/ 
played in in lake 
water 
3.72 (1.44 to 
9.61) 0.007 
1.28 (0.39 to 4.20) 
0.69 
0.98 (0.27 to 
3.52) 0.97 
Walked on 2.44 (1.04 to 1.70 (0.66 to 4.42) 1.79 (0.65 to 
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Risk Factor Univariable 
(n=223) 
Multivariable for 






beaches 5.74) 0.04 0.27 4.92) 0.26 
Resistance to tetracycline (n=81) 
Fed raw food 4.47 (2.21 to 
9.05) <0.001 
4.47 (2.21 to 9.05) 
<0.001 
3.52 (1.67 to 
7.40) 0.001 
Swum/ paddled/ 
played in pond 
water 
1.80 (1.00 to 
3.25) 0.05 
1.68 (0.91 to 3.12) 
0.10 
1.657 (0.75 to 
3.27) 0.23 
Resistance to amoxicillin (n=93) 
Fed raw food 3.30 (1.64 to 
6.63) 0.001 
3.18 (1.57 to 6.42) 
0.001 
2.55 (1.23 to 
5.30) 0.01 
Swum/ paddled/ 
played in pond 
water 
2.01 (1.12 to 
3.61) 0.02 
1.91 (1.05 to 3.48) 
0.04 
1.80 (0.93 to 
3.47) 0.08 
Resistance to cephalexin (n=34) 
Resistance to streptomycin (n=51) 
Fed raw food 8.23 (3.95 to 
17.15) <0.001 
8.23 (3.95 to 
17.15) <0.001 













Table 3.5. Univariable and multivariable logistic regression analyses using 
questionnaire data and AMR E. coli data for 16-week-old puppies recruited via 
Generation Pup, excluding samples with a limit of detection issue where the E. 
coli count was less than 20 cfu or missing or incomplete questionnaires (n=223). 
Only significant results are shown, the full results are present in the appendix. 
Presentation: Odds ratio (95% confidence interval) p-value. A p-value was 
considered significant if p<0.05. 
Risk Factor Univariable (n=182) Multivariable for 
Generation Pup 
Samples (n=182) 
Resistance to any antibiotic (n=94) 
Autocoprophagic 
behaviour in past 
seven days 
0.28 (0.09 to 0.90) 
0.03 
0.22 (0.06 to 0.83) 
0.03 
Resistance to ciprofloxacin (n=24) 
   
Resistance to tetracycline (n=72) 
Autocoprophagic 
behaviour in past 
seven days 
0.19 (0.04 to 0.88) 
0.03 
0.10 (0.01 to 0.80) 
0.03 
Resistance to amoxicillin (n=82) 
Autocoprophagic 
behaviour in past 
seven days 
0.25 (0.07 to 0.91) 
0.04 
0.18 (0.04 to 0.82) 
0.03 
Resistance to cephalexin (n=30) 
Rolled in cow pats 5.56 (1.06 to 28.98) 
0.04 
5.52 (1.06 to 
28.79) 0.04 
Resistance to streptomycin (n=51) 
Rolled in cow pats 6.63 (1.17 to 37.53) 
0.03 
11.42 (1.51 to 
86.17) 0.02 
 
In conclusion, this research has identified factors such as raw feeding and rolling 
in cow pats as risks for carrying AMR E. coli in 16-week-old puppies. It is essential 
that puppy owners fully understand the risk that these practices - especially raw 
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feeding - pose to the health of their puppy, other animals, themselves and their 
contribution to the global problem of AMR. Owner education is essential, and 
suggestions to mitigate this risk should be encouraged (i.e. owners should be 
instructed to feed their puppies cooked meat or dry food instead of raw food). It 
may also be necessary to decrease the use of antibiotics used in food-producing 
animals in order to decrease the risk of AMR bacteria being transmitted to dogs 
as well as regulate the importation of raw meat used for feeding dogs. The 
strategy of the Responsible Use of Medicines in Agriculture (RUMA) Alliance is 
that the health and welfare of food-producing animals is important but that 
antimicrobials should be used responsibly. RUMA also suggest that good 
management practices can reduce disease which helps reduce the need for 
antimicrobials (RUMA 2012). Furthermore, they suggest that antimicrobials 
should be prescribed by a veterinary surgeon and that a full course of treatment 
should be completed, as well as that critically important antimicrobials should 
never be given preventively or as the first treatment for livestock (RUMA 2012). 
It is also important that a strategy is in place for responsible use of antimicrobials 
in small animals, the BSAVA (British small animal veterinary association) 
recommend the PROTECT guidelines to promote responsible antimicrobial 
prescribing. For example, these guidelines advise veterinarians that they should 
consider other options for treatment before prescribing antimicrobials, ensure the 
correct antimicrobial is used and ensure that treatment is carried out effectively 
(BSAVA 2018).  
Further research could be conducted into the brands and sources of the raw food 
that was fed to the puppies in this study in order to assess whether all raw food 
products are as much of a risk for resistance carried by puppies. This could be 
done by surveying puppy owners that raw feed their dogs. It would also be 
beneficial to investigate AMR in the owners of the puppies to evaluate whether 
resistance is being spread between members of the household. Further research 
is also needed to further evaluate the hypothesis that autocoprophagic habits in 
the young puppies was protective against resistance to assess the reasons 
behind this. There were some other trends and hypotheses identified by the risk 
factor analysis which all need to be investigated to assess whether the factors 
are actual risk factors for the carriage of AMR in dogs. 
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Chapter 4 – Adult dogs and comparison of cohorts 
 
4.1 Introduction 
In this chapter, AMR in adult dogs was investigated and comparisons were made 
between adult dogs recruited from different areas in the UK. In Chapter 3 there 
was an indication that swimming in lake water was a risk factor for ciprofloxacin 
resistance (Univariable: 3.72 (1.44 to 9.61) p=0.007) and playing in pond water 
was a risk factor for both amoxicillin resistance (Multivariable: 1.91 (1.05 to 3.48) 
p=0.04) and tetracycline resistance (Univariable: 1.80 (1.00 to 3.25) p=0.05) in 
16-week-old puppies. This suggested that interaction with different types of water 
may increase the risk of AMR in young puppies. Hence, a preliminary cohort of 
adult dogs was recruited to assess whether swimming in water sources was a 
risk factor for carrying AMR E. coli. Previous studies have found a correlation 
between humans that surf in UK coastal salt water and gut carriage of AMR 
bacteria, presumably as a result of accidental ingestion (Leonard et al. 2017). It 
is therefore possible that dogs that ingest pond/river/sea water may be at a 
greater risk of carrying AMR E. coli. A cohort of adult dogs that were locally 
recruited were compared to the adult dogs recruited from Oxfordshire to assess 
regional differences. Regional differences in the locally recruited 16-week-old 
and Generation Pup-recruited 16-week-old puppies (nationally recruited) were 
also compared. 
Furthermore, in Chapter 3 the research focused on puppies aged 16 weeks to 
explore risk factors associated with AMR. Therefore, this chapter considered 
AMR in a cohort of recruited adult dogs to assess whether there was a difference 
in the carriage of AMR E. coli in the adult dogs compared to the young puppy 
cohorts. In the UK, common veterinary advice is not to walk puppies under 12 
weeks of age in public places as puppies are usually not fully vaccinated. By 16 
weeks of age, vaccinations are normally complete and puppies are usually 
walked freely in public places. Therefore, for a subgroup of puppies, comparisons 
in this study were also made between the levels of AMR E. coli in faeces from 
puppies ≤12-weeks of age versus 16-weeks of age to capture the influence of 
this initial interaction with the wider environment on AMR carriage. It is possible 
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that the age of a dog affects the amount of AMR E. coli that the dog has in its gut 
and very few studies have investigated whether age affects AMR carriage in 
dogs. Hence, in this study AMR in the E. coli obtained from puppies at 16-weeks-
old were compared with that of adult dogs. The methods used are shown in 
Chapter 2. 
 
4.2 Results and Discussion  
 
4.2.1 Adult dogs  
A total of 34 adult dogs were recruited for this study (18 locally recruited, 16 
recruited from the Oxfordshire catchment area). The 18 locally recruited dog 
owners completed questionnaires, and these were used to determine possible 
risk factors for AMR E. coli carriage in faeces. Only 14 of these 18 dogs were 
screened for AMR E. coli; four were excluded due to a limit of detection issue 
where the E. coli count was less than 20 cfu. Of the 16 dogs recruited from the 
Oxfordshire area, only 11 were screened for AMR due to the same issue around 
limits of detection (Table 4.1). 
 
Table 4.1 Number of faecal samples and completed samples for locally recruited 
and Oxfordshire adult dogs. Samples that had a limit of detection issue where 
the E. coli count was less than 20 cfu were excluded as were adult samples that 









Adult Dogs 18 16 
Screened 14 11 
Excluded 4 5 
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The locally recruited adult dog faecal samples were tested for AMR E. coli and 
these results were paired with the questionnaire responses. Pearson chi-squared 
tests were performed as initial analyses and there were no significant risk factors 
found when comparing responses from the questionnaire with whether or not the 
sample had AMR E. coli (Table 4.2). Univariable and multivariable logistic 
regressions were also carried out on the locally recruited adult dogs and no 
significant risk factors were found (Appendix). This part of the study may have 
been limited in power - a larger cohort of adult dogs may have provided evidence 
for potential risk factors associated with AMR. 
 
Table 4.2 Baseline data for locally recruited adult dogs (n=14) showing potential 
risk factors from questionnaire responses and faecal AMR E. coli resistance. p-
values were calculated using Pearson chi-squared tests. A p-value <0.05 was 
considered significant.  











Fed raw food 
 
Yes 1 1/1 0.23 
No 13 5/13 
Walked around roads and 
streets 
 
Yes 10 3/10 0.12 
No 4 3/4 
Walked in parks 
 
Yes 6 2/6 0.53 
No 8 4/8 
Walked on beaches 
 
Yes 10 10/4 0.42 
No 3 2/3 
Yes 14 6/14 / 
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Walked in the countryside 
without animals 
 
No 0 0 
Walked in the countryside 
with other animals 
present 
 
Yes 12 5/12 0.83 
No 2 1/2 
Walked in the countryside 
with cattle present 
 
Yes 12 5/12 0.83 
No 2 1/2 
Swum/ paddled/ played in 
salt water 
Yes 6 2/6 0.53 
No 8 4/8 
Swum/ paddled/ played in 
lake water  
Yes 5 2/5 0.87 
No 9 4/9 
Swum/ paddled/ played in 
river water  
Yes 9 5/9 0.20 
No 5 1/5 
Swum/ paddled/ played in 
pond water  
Yes 7 4/7 0.28 
No 7 2/7 
Recently had antibiotics 
 
Yes 2 0/2 0.19 
No 12 6/12 
Walked frequently around 
cattle 
Yes 11 4/11 0.35 
No 3 2/3 
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4.2.2 Regional comparison in adult dogs 
The two differently recruited adult dog cohorts (Locally recruited and Oxfordshire 
recruited adult dogs) could be compared for resistance to the five different 
antibiotics (ciprofloxacin, tetracycline, amoxicillin, cephalexin and streptomycin) 
in E. coli found in the faecal samples (Table 4.3). A significant difference in 
amoxicillin resistance was shown between the cohorts - the Oxfordshire dogs 
were more likely to carry E. coli with amoxicillin resistance compared to the locally 
recruited dogs (p=0.02; Table 4.3).  
A possible hypothesis to explain the significant difference in amoxicillin 
resistance could be that the Oxfordshire dogs were recruited in an area close to 
river water and the ingestion of water may be a risk factor for carrying E. coli with 
amoxicillin resistance. A paper examining the impact of human surfers swimming 
in UK coastal water found that surfers were at risk of exposure and colonisation 
by AMR E. coli (Leonard et al. 2017). These authors indicated that there was a 
possibility that the natural environment played a role in the transmission of AMR 
bacteria and that natural waters may act as important reservoirs of AMR bacteria 
(Leonard et al. 2017). If natural waters such as rivers, sea and lakes act as 
reservoirs for resistant bacteria it is possible that dogs swimming in the River 
Thames could be ingesting water contaminated with resistant E. coli. This could 
potentially increase the prevalence of amoxicillin-resistant E. coli in the gut of 
adult dogs that are recruited in close proximity to the River Thames compared to 
dogs that were recruited in the Bristol area. However, this would require further 
research into the impact a water environment could have on AMR and more work 
would need to compare the environments in the different regions. 
It could be postulated that the difference in amoxicillin resistance in the 
Oxfordshire-recruited dogs compared to the locally recruited dogs could be 
because of differences in veterinary practices in those areas. The locally 
recruited dogs were predominately recruited through one veterinary practice and 
their antimicrobial prescription policies may influence the amount of amoxicillin-
resistant bacteria found in the adult dog population in that region. Furthermore, 
the Oxfordshire dogs were recruited from a relatively small area and therefore it 
is possible that adult dogs went to the same veterinary practices and their 
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antimicrobial prescription policies may have influenced the amount of amoxicillin 
given to that dog population. Again, we did not collect data to test this hypothesis, 
but evidence has been found that AMR develops in response to treatment and 
that antimicrobials are frequently prescribed to small animals, including dogs 
(Trott et al. 2004; Singleton et al. 2017). Recent studies in the UK indicated that 
25% of dogs seen at veterinary practices received at least one antimicrobial 
prescription (Singleton et al. 2017; Buckland et al. 2016). Research into 
antimicrobial prescribing in small animals also found that amoxicillin-clavulanate 
was the most commonly prescribed antimicrobial in small animal practices in the 
UK (Radford et al. 2011). Amoxicillin was the second most prescribed 
antimicrobial (20% of total prescriptions), however, these authors did find 
variation between different practices in the amount and types of antimicrobials 
being prescribed (Radford et al. 2011). A possible hypothesis for the results of 
this study, therefore, could be that the locally recruited dog veterinary practices 
do not prescribe amoxicillin as often as the veterinary practices  in comparison 
to the Oxfordshire recruitment area. This might result in selection for amoxicillin-
resistant bacteria in the Oxfordshire adult dog population.  
The high levels of amoxicillin and amoxicillin-clavulanate prescriptions for dogs 
in the UK may contribute to AMR in the UK (especially amoxicillin resistance). 
Clavulanic acid is an inhibitor of TEM and SHV b-lactamases, which cause 
amoxicillin resistance (Sulton et al. 2005), therefore it is unlikely that these 
resistance genes would be detected in amoxicillin-resistant E. coli if the usage of 
amoxicillin-clavulanate contributes to amoxicillin resistance in the E. coli carried 
by dogs. Instead, amoxicillin-clavulanate use is likely to select for b-lactamases 
that are not inhibited by clavulanic acid, such as AmpC enzymes. This is likely to 
occur due to chromosomal mutations on the ampC promoter causing AmpC 
hyperproduction or due to production of a plasmid-derived CMY enzyme. These 
possibilities are explored in Chapter 5. 
There were no significant differences in resistance to any of the other antibiotics 
in E. coli carried by the local dogs and Oxfordshire dogs (Table 4.3); the 
difference in AMR between the two areas was only detected with regards to 
amoxicillin. This could be because it was not possible to detect any differences 




Table 4.3 Differences in the carriage of E. coli resistant to five different antibiotics 
(ciprofloxacin, tetracycline, amoxicillin, cephalexin and streptomycin) in faecal 
samples from adult dogs recruited locally and from the Oxfordshire. P-values 
were calculated using Fisher’s Exact Test. 
 
4.2.3 Regional comparison in 16-week-old puppies 
Some of the puppies recruited for this study were specifically recruited in the local 
area (Somerset, North Somerset, Bath and Bristol) although the majority of 
puppies were recruited throughout the UK by Generation Pup (Chapter 3). 
However, all samples were obtained when the puppy was 16-weeks-old and were 
processed and treated in exactly the same way. It was therefore possible to 
compare the number of puppies carrying E. coli with resistance to the five 
antibiotics to see whether there was a difference in the amount of resistance 
between the two groups. We compared the number of 16-week-old puppy 
samples that had resistant E. coli from the locally recruited cohort of puppies with 
the nationally recruited puppies (Generation Pup; Table 4.4). The results showed 
a significant difference in amoxicillin and tetracycline resistance in the E. coli 
obtained from locally recruited 16-week-old puppies and Generation Pup-







Any antibiotic 6/14 8/11 0.14 
Ciprofloxacin 2/14 3/11 0.62 
Tetracycline 4/14 5/11 0.43 
Amoxicilin 3/14 8/11 0.02 
Cephalexin 3/14 1/11 0.60 
Streptomycin 3/14 4/11 0.66 
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(p=0.04; Table 4.4) and tetracycline (p=0.05; Table 4.4) resistance. This regional 
difference in AMR could be due to differences in antimicrobial prescribing policy 
by veterinary practices in the local area compared to the national policy. For 
example, local veterinary practices may prescribe less amoxicillin and 
tetracycline compared to the national average. In order to investigate this, further 
research could compare the prescription data of the veterinary practices. 
However, this difference could be due to other regional differences in the 
environment and in the dog population. This regional difference in amoxicillin was 
also found in the adult dogs (Table 4.3). 
 
Table 4.4 Number of puppy faecal samples carrying E. coli resistant to any of the 
five different antibiotics (ciprofloxacin, tetracycline, amoxicillin, cephalexin and 
streptomycin) from 16-week-old locally recruited puppies to nationally recruited 
(Generation Pup) puppies. P-values were calculated using Fishers Exact Test.  







old) with resistance 
p-value 
Ciprofloxacin 2/41 24/182 0.18 
Tetracycline 9/41 72/182 0.05 
Amoxicilin 11/41 82/182 0.04 
Cephalexin 4/41 30/182 0.34 
Streptomycin 6/41 45/182 0.22 
 
4.2.4 Comparison of AMR E. coli in different ages of dogs that were locally 
recruited  
As part of the wider study presented here, dogs were recruited at three different 
ages in order to investigate whether or not age affects AMR E. coli carriage. All 
puppies and dogs were recruited from the same local area. It was therefore 
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possible to compare resistance in the locally recruited 12-week-old and locally 
recruited 16-week-old puppies with resistance in locally recruited adult dogs. 
Samples from 12-week-old and 16-week-old puppies were compared from the 
same group of animals, however, adult dogs were a separate cohort.  
In the UK, puppies are recommended to receive a course of core vaccinations in 
order to provide them with life-long protection against some infectious diseases 
(canine distemper virus, canine adenovirus, canine parvovirus type 2 and other 
variants). In the first weeks of life, puppies are protected by maternally derived 
antibodies but this diminishes by 8-12 weeks of age to a level that allows active 
immunization. It is currently recommended that puppies receive a core 
vaccination at 6-8 weeks of age and then every 2-4 weeks until 16 weeks of age 
(Day et al. 2016). Puppy owners are usually advised by veterinarians to not  walk 
their puppy outside in public places until after the puppy has had its second 
vaccination (approximately 12 weeks of age). Due to this recommendation, the 
majority of puppies under 12 weeks have not been walked outside in public 
places, although at 16 weeks puppies are vaccinated and able to walk in public 
places. It was therefore possible and interesting to assess whether walking in 
public places affects the amount of resistant E. coli puppies carry. 
The puppies at 12-weeks-old were compared with the same puppies at 16-
weeks-old to see whether the puppies gained or lost AMR E. coli carriage. (Table 
4.5). The data showed that there is a significant difference in carriage of 
amoxicillin-resistant E. coli at 12 weeks compared to 16 weeks (p<0.001). The 
same cohort of puppies at 12-weeks-old were more likely to be carrying 
amoxicillin resistant E. coli than at 16-weeks-old. A longitudinal study would need 
to be conducted to fully investigate this. There was no significant difference for 
resistance to any other antimicrobial. When comparing the resistance of the E. 
coli obtained from each puppy’s faecal sample individually, there was no 
correlation between puppies carrying resistance to any of the five antimicrobials 
at 12 weeks compared to 16 weeks. 
If guidelines are being followed, it might be expected that the 12-week-old 
puppies are exercising less (if at all) in public places than the 16-week-old 
puppies, so it was interesting to find that these young puppies are more likely to 
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carry amoxicillin-resistant E. coli.  
This indicates that puppies have already been exposed to AMR bacteria and 
have acquired AMR E. coli very early in life, potentially from their mothers during 
birth or in early life. A previous investigation of spread of AMR E. coli amongst 
puppies in breeding kennels found that resistant bacteria spread between 
puppies in the same litter as well as amongst puppies bred and raised in close 
proximity (Harada et al. 2011). Perhaps puppies are directly receiving amoxicillin-
resistant E. coli from their mothers which remain in their gut but diminish as the 
puppy ages. Future work to test this could be to take a number of different 
puppies from birth and test for amoxicillin resistant E. coli regularly to evaluate 
whether the move to the domestic home influences resistance. 
A possible hypothesis is that puppies acquire amoxicillin-resistant bacteria at 
birth, however, the amount of resistant bacteria is amplified whilst in the litter, 
either through human contact and handling or due to changes in the gut of the 
puppy that select for E. coli with amoxicillin resistance. It could be postulated that 
the move from the litter to the domestic environment with different humans that 
handle the puppy may amplify amoxicillin resistance in the E. coli in puppies at 
12 weeks, but that this decreases over time. One reason for this could be 
because the humans are transmitting amoxicillin-resistant E. coli to the puppies 
and creating a selection pressure for amoxicillin resistance in the E. coli carried 
by the puppies. 
Research into AMR in European dogs has suggested that a large number of dog 
breeders frequently treat bitches with antimicrobials before and after they give 
birth with the aim of eliminating bacterial flora and reducing neonatal mortality; 
however, the consequence of this has been shown to be selection for resistant 
bacteria (Milani et al. 2012). The most commonly prescribed antimicrobials for 
this purpose were found to be amoxicillin-clavulanic acid or amoxicillin (Milani et 
al. 2012) and this could be a possible explanation for the high levels of amoxicillin 
resistance in young puppies. Further research would need to be conducted to 
test all of these hypotheses.  
Further possible explanations could be that there is a correlation between the 
age of the dog and prescription of antimicrobials by veterinary practices; a 
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previous study found that antimicrobial usage decreased with an animal’s age 
(Radford et al. 2011). Therefore, it is conceivable that the 12-week-old puppy 
population was more likely to receive antimicrobials (including amoxicillin) 
compared to 16-week-old puppies; this could increase amoxicillin resistance 
found in the E. coli obtained from the faecal samples.  
However, it is clear that amoxicillin resistant E. coli colonises the puppies before 
12-weeks of age and that by 16-weeks-old the number of puppies carrying 
amoxicillin resistance has dramatically decreased (Table 4.5). The reason for this 
decrease is not certain, but it may be to do with the puppies’ exercising in public 
places and therefore presumably being exposed to a greater variability of 
bacteria compared to puppies at 12 weeks who are still mostly with their 
littermates. This could increase competition, reducing the abundance of 
amoxicillin-resistant bacteria in the puppy in the absence of selection (Table 4.5). 
The results did not show a significant difference in the number of puppies with E. 
coli showing resistance to the other antibiotics at 12 weeks compared to 16 
weeks, suggesting that whatever happens to select for amoxicillin resistance 
does not select for resistance to the other drugs.  In fact, there is a reduction of 
resistance in all cases, so perhaps the reality here is that whatever is happening 
for amoxicillin is far stronger than what is happening for other agents. It is 
important to note that amoxicillin resistance in 12-week-old puppies has a 
prevalence more than double the next most common resistance, but at 16 weeks 
its prevalence is similar to that of resistance to other agents. This suggests that 
the causative factor for amoxicillin resistance early on is strong selection, rather 
than active selection against amoxicillin resistance later on as, resistance in 









Table 4.5 Number of puppy faecal samples carrying E. coli resistant to any of the 
five different antibiotics (ciprofloxacin, tetracycline, amoxicillin, cephalexin and 
streptomycin) from the same puppies at 12 weeks and 16 weeks. P-values were 






Ciprofloxacin 5/41 2/41 0.43 
Tetracycline 14/41 9/41 0.33 
Amoxicilin 33/41 11/41 <0.001 
Cephalexin 8/41 4/41 0.35 
Streptomycin 12/41 6/41 0.18 
 
The amount of resistance to the five antimicrobials in the E. coli obtained from 
the locally recruited 16-week-old puppy faecal samples was compared with that 
from locally recruited adult dog cohort samples (Table 4.6). There were no 
significant differences between resistance in the E. coli from the locally recruited 
16-week-old puppy samples and locally recruited adult dog samples found (Table 
4.6).  
This could indicate that by 16-weeks-old puppies that are able to walk freely in 
public places and are exposed to the natural environment as well as other 
humans and animals have a wider variety of gut bacteria. This study shows that 
resistance at 16 weeks is similar to that seen in adult dogs. It may also indicate 
that the locally recruited 16-week-old puppies and locally recruited adult dogs 
have similar levels of resistance and this could be because they attend the same 
veterinary practices with similar antimicrobial prescribing policies and live in the 
same region (e.g. they walk in the same areas and are part of the same local dog 
population), so differences are not evident.  
A significant difference was shown between the number of puppies with 
amoxicillin-resistant E. coli (higher at 12 weeks compared to the same puppies 
at 16 weeks; p<0.001; Table 4.5).  It is possible that the high levels of resistance 
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seen in 12-week-old puppies (perhaps driven by maternal transmission) very 
quickly falls off after puppies start to interact with the environment and the 
puppies become more like the adult dog population in terms of resistance. 
However, another possible hypothesis to explain the relatively high levels of 
amoxicillin resistance seen in 12-week-old puppies could be that puppy owners 
are likely to acquire their puppy from a wide geographical area. Even the ‘locally 
recruited’ 12-week-old puppies may have come from a variety of places in the 
UK where amoxicillin resistance levels may be higher, as seen in the Generation 
Pup and Oxfordshire adult dogs (Table 4.3 and 4.4). This hypothesis would need 
to be investigated further as data on where the puppies originated from was not 
included in this study. Irrespective of the source of these high levels of amoxicillin 
resistance in 12-week-old puppies, by 16 weeks the resistance in E. coli carried 
by the puppies was more representative of the local area was lower than what 
was found in dogs from a wider geographical range (Table 4.5; Table 4.6). It was 
shown that the adult Oxfordshire dogs and the Generation Pup 16-week-old 
puppies had higher amoxicillin resistance compared to locally recruited dogs 
(Table 4.3 and 4.4).  
Table 4.6 Resistance to five different antibiotics (ciprofloxacin, tetracycline, 
amoxicillin, cephalexin and streptomycin) in E. coli from 16-week-old puppies 
compared to adult locally recruited dogs. P-values were calculated using Fisher’s 
Exact Test. 
 Local 16-week-old 
puppies 
Local Adult dogs p-value 
Ciprofloxacin 2/41 2/14 0.27 
Tetracycline 9/41 4/14 0.72 
Amoxicilin 11/41 3/14 1.00 
Cephalexin 4/41 3/14 0.35 
Streptomycin 6/41 3/14 0.68 
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In conclusion, the comparison of resistance between dogs of different ages 
showed that amoxicillin resistance in E. coli was higher in 12-week-old puppies 
compared to 16-week-old puppies whereas there was no significant difference 
between resistance to any antibiotic between 16-week-old puppies and adult 
dogs. Further research could be conducted to investigate the impact of the 
domestic environment has on resistance in young puppies and whether there is 
any amplification of resistance in puppies due to being handled by humans. 
Furthermore, studies could compare veterinary practices with different 
antimicrobial prescription policies to evaluate whether these practices impact the 
amount of resistance found in the local dog population. Amoxicillin resistance in 
the E. coli carried by dogs was also found to be significantly lower in adult dogs 
compared to young puppies as well as lower in the local area when comparing 
the location of the recruitment of the dogs. Therefore, it would be useful to collect 
amoxicillin-resistant E. coli isolates and sequence the whole genome of the E. 



















Chapter 3 identified potential risk factors associated with AMR in the E. coli 
carried by 16-week-old puppies. The aim of the work in this chapter was to 
investigate the mechanisms responsible for this resistance. The 16-week-old 
puppy faecal samples with E. coli colonies that were cephalexin-resistant 
(Chapter 3) were first tested for cefotaxime (3rd generation cephalosporin) 
resistance. A series of multiplex PCRs were carried out on a number of the 
cefotaxime-resistant E. coli isolated from the 12-week-old, 16-week-old or adult 
dog samples to detect b-lactamase genes (carried out by Jacqueline Findlay). 
The 16-week-old puppy cefotaxime- or ciprofloxacin-resistant E. coli were sent 
off for whole genome sequencing to elicit details about the specific E. coli 
including the ST, the presence of b-lactamase genes and other resistance genes. 
MLST was carried out on the cefotaxime-resistant and ciprofloxacin-resistant E. 
coli obtained from the 16-week-old puppy faecal samples (carried out by 
Jacqueline Findlay and Oliver Mounsey). It was not possible to carry this out on 
all of the cephalexin- and ciprofloxacin-resistant E. coli. The methods were 
carried out as described in Chapter 2.  
 
5.2 Results and Discussion 
 
E. coli from the 12-week-old puppies, 16-week-old puppies and adult dog 
samples that were cephalexin-resistant were tested for cefotaxime resistance 
and any resistant E. coli then had a series of multiplex PCRs carried out on them. 
The results from the PCR showed that it was possible, in some isolates, to 
identify the presence of known ESBL b-lactamase genes and the presence of 
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ampC which are known to confer cefotaxime resistance. It can be assumed that 
the mechanism for cefotaxime resistance in the E. coli with a negative result on 
PCR for known cefotaxime resistance genes would be AmpC hyperproduction 
due to chromosomal mutations in the ampC promoter. Of the faecal samples 
obtained from the 16-week-old puppy samples, 20 had E. coli that were resistant 
to cefotaxime. The number of the dogs and puppies with each gene were 
identified. For example, seven out of 20 16-week-old puppies were shown to 
have a Group 1 CTX-M gene (Table 5.1). CTX-M-1 is the most commonly found 
ESBL type in European livestock and the second most common type associated 
with clinical human isolates in some countries including France and Italy 
(Kjeldsen et al. 2015). Furthermore, CTX-M-15 has been described as one of the 
most important types as it is found in nearly all human and animal populations 
and environments all across the world and has rapidly spread across the UK 
since its first detection (Cantón et al. 2012). Both of these enzymes are from 
CTX-M Group 1. Plasmid-mediated AmpC b-lactamase carriage was also found 
in the cefotaxime-resistant E. coli from six of the 16-week-old puppies, the genes 
being blaCMY-2, and blaDHA-1 (Table 5.1). CMY genes have been found in E. coli 
from sick and healthy dogs throughout the world, which suggests that these 
genes are common in dogs (Rocha-Gracia et al. 2015). It has been suggested 
that the high frequency of this gene in dogs is because of the spread of a few 
specific plasmids or the integration of this gene into many plasmids which has 
resulted in the spread of this plasmid throughout the UK dog population (Wedley 
et al. 2017). The PCR results in this study, however, show that puppies had a 
range of different genes detected their cefotaxime-resistant E. coli. Seven of the 
E. coli isolated from the 16-week-old puppies were found to be cefotaxime-
resistant but had a negative result on PCR. A possible explanation for this could 
be that the mechanism for the E. coli to have cefotaxime resistance was 







Table 5.1 Results from the PCR showing the number of 12-week-old and 16-
week-old puppies or adult dogs that have CTX-M Groups 1 or 9, OXA-1, CMY, 
DHA, or TEM. The E. coli tested were all cefotaxime-resistant.  






Number of adult 
dog samples 
(n=2) 
CTX-M G1 1 7 1 
CTX-M G9 2 1 0 
blaCMY 4 4 1 
blaDHA 0 1 0 




2 7 0 
 
The cefotaxime-resistant E. coli from the 16-week-old puppy samples had whole 
genome sequencing carried out and the resulting data used to perform MLST. E. 
coli from samples obtained from puppies without completed questionnaires were 
excluded and those that were from 16-week-old puppies that were cefotaxime-
resistant were included (n=20 E. coli colonies from 20 different puppies). This 
allowed identification of the ST to which the resistant E. coli belonged. Using a 
database, it was then possible to identify the other sources from which those 
particular ST has been found (not all E. coli in the database were necessarily 
resistant; Enterobase https://enterobase.warwick.ac.uk/; Table 5.2). This 
database does not show how commonly each ST is found in each source and 
only details that the specific STs has been found once before in that source. It 
was not possible to identify other places that ST6096 and ST2179 has been 
previously identified through the database (Table 5.2).  
The molecular results from this chapter provide further information about AMR in 
E. coli from dogs and the possible acquisition of resistance through food, from 
other dogs and from other species and environments. These findings also 
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provide some evidence of the sharing of resistant E. coli between dogs and other 
species. There was a wide variety of different sequence types observed, with 16 
different sequence types found (Table 5.2).  
ST38, ST88 and ST10 have been reportedly been found in companion animals, 
livestock, wildlife and humans (Table 5.2; Ewers et al. 2012), indicating that some 
STs are widespread and found in many different animals and environments, 
including dogs. Many of the STs have been identified in dogs in the UK in the 
past. For example, ST10, ST963 and ST88 have all been reported in dogs in the 
UK (Wedley et al. 2017), suggesting that some STs are commonly found in dogs. 
Using Enterobase, it was possible to identify that ST372 and ST973 have been 
found in companion animals previously suggesting that these may be commonly 
found in dogs. Another study that carried out MLST on AMR dog samples also 
found E. coli with ST973, ST963 and ST372 (Melo et al. 2016), adding weight to 
the argument that these sequence types are found regularly in dogs.  
In Chapter 3, analyses were carried out to assess whether there were risk factors 
that increased the risk of puppies carrying AMR E. coli. It was found puppies that 
rolled in cow pats had a greater risk of carrying E. coli with cephalexin resistance 
(Table 3.3). This indicates that agriculture - especially cattle - may contribute to 
the transmission of AMR to dogs. Three of the 16-week-old puppies had 
reportedly rolled in cow pats and had ST88, ST58 or ST3889; all of these 
sequence types have also been found in livestock (Tables 3.3 and 5.2). 
Therefore, this could suggest that the dogs are acquiring resistant E. coli from 
cow pats. However, ST88 is commonly found in companion animals, livestock, 
humans and wildlife, so more evidence will be needed to firmly link livestock to 
puppy E. coli (Ewers et al. 2012).  
Of the 20 E. coli obtained from the puppy samples, 19 of STs found have been 
found previously in humans; this suggests that dogs and humans share many of 
the same STs. It is possible that E. coli is shared within a household among pets 
and humans. In fact, this host-to-host transmission has been found in many 
studies and this may facilitate the spread of AMR within the community (Johnson 
et al. 2008; Damborg et al. 2009; Grönthal et al. 2018). Research that evaluated 
the relationship of ESBL and AmpC production with multidrug resistant E. coli 
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isolated from clinical cases of canine urinary tract infection from 2002 to 2011 
from the UK have also been compared to human samples from the same local 
area (Wagner et al. 2014). These authors also found ST372, ST10, ST744 and 
ST73 in the E. coli from the dog samples they obtained which were also found in 
this study (Table 5.2). However, these authors did not find enough evidence to 
suggest that there was a zoonotic spread of resistance between dogs and 
humans using ST results (Wagner et al. 2014). However, other studies have 
found evidence that dogs share similar strains of ESBL-producing genes which 
suggests household transmission (Baede et al. 2017).  
 
Table 5.2 Sequence types found in cefotaxime-resistant E. coli from the 16-
week-old puppy samples and possible other sources where the sequence type 
has been found before using Enterobase. The questionnaire data of whether 
these puppies were reported to have rolled in cowpats or were raw fed is also 
included as this was significant in the risk factor analysis (Yes, No, / indicates 











1 6096  No No 
2 963 Human, Water, Livestock, Wild 
Animals 
/ No 
3 88 Human, 
Companion/domesticated 
Animals, Poultry, Bird, livestock 
Yes Yes 
4 58 Human, livestock, domesticated 
animals, poultry 
Yes No 
5 155 Human, Bovine, Animal, 






Animals, Poultry, Bird, livestock 
No Yes 












8 10 Human, Companion Animal, 
Livestock 
No No 
9 1196 Human, Environment, Poultry No No 
10 215 Human, Poultry, Livestock, 
Environment 
No No 
11 75 Companion Animal, Poultry, 
Livestock, Human, Environment 
No No 
12 744 Human, Bird, Poultry, Livestock, 
Environment 
No No 
13 3889 Animal, Companion Animal, 
Human, Poultry, Livestock 
Yes No 
14 973 Poultry, Livestock, Human, 
Environment, Companion 
Animal, Wild Animal 
No No 
15 372 Companion Animal. 
Domesticated Animal, Poultry, 
Human 
No No 
16 744 Human, Bird, Poultry, Livestock, 
Environment 
No Yes 
17 38 Human, Wild Animal, Poultry, 
Bird, Companion Animal 
No No 
18 88 Human, Companion/ 
domesticated Animals, Poultry, 
Bird 
No No 
19 88 Human, Companion/ 
domesticated Animals, Poultry, 
Bird 
/ Yes 






There were 20 E. coli that were cefotaxime-resistant isolated from the 16-week-
old puppies and these had their b-lactamase genes detected using whole 
genome sequencing (Table 5.3). The genes found indicate the type of resistance 
that the puppy carried and it is possible to identify whether some genes are more 
common than others. Four puppies were found to have blaCMY-2 and four were 
found to have blaCTX-M-1; these were therefore the most commonly found genes 
detected in the cefotaxime-resistant E. coli. Three of the puppies were found to 
carry E. coli with blaCTX-M-15 which is commonly found in humans (Cantón et al. 
2012). The whole genome sequencing results matched the results found with 
PCR (Table 5.1; Table 5.3). Out of the 20 puppy E. coli samples, three had blaTEM-
1B or blaTEM-78 (Table 5.8). TEM-1 b-lactamases act by hydrolysing the b-lactam 
ring of antimicrobials and are found in both humans and animals across the world 
(Salverda et al. 2010). 
The whole genome sequencing confirmed the PCR results - seven of the E. coli 
isolated from the 16-week-old puppies (three, four, five, six, seven, eleven and 
nineteen) have ampC promoter changes which caused AmpC hyperproduction 
that resulted in the destruction of the cefotaxime antimicrobial molecules, 
resulting in resistance (Table 5.3). A study examining prescribing at small animal 
veterinary practices in the UK found that clavulanic acid-potentiated amoxicillin 
was the most common antimicrobial prescribed (36%) and amoxicillin was the 
second most prescribed antimicrobial (20%; Radford et al. 2011). It could 
therefore be hypothesised that the dominance of AmpC found in the E. coli 
carried by dogs could be because of the high levels of usage of amoxicillin-type 
antimicrobials in the dog population. Nine of the 16-week-old puppies had ESBL 
genes (which are mediated by plasmids) detected. The rapid emergence and 
spread of ESBLs poses a serious health risk as multiple antimicrobials (such as 
third generation cephalosporins) used to treat infections caused by ESBL-





Table 5.3 b-lactamase genes detected in the sequenced E. coli. The E. coli was 
obtained from 16-week-old puppies and were found to be cefotaxime-resistant. 
Genes detected include blaCMY-2 and blaCTX-M-15; genes detected from each of 
these puppies is included. 
16-week-old puppies 














































1 Y  Y      
2   Y     Y 
3         
4         
5         
6         
7         
8    Y     
9     Y    
10      Y   
11         
12    Y     
13  Y    Y   
14   Y      
15   Y      
16    Y     
17      Y  Y 
18    Y     
19         
20  Y     Y Y 
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From the sequencing of the cefotaxime-resistant E. coli isolated from the 16-
week-old puppies, it was possible to detect other resistance genes which could 
potentially correspond to resistance to different antimicrobials. There was a wider 
range of AMR genes found in the puppy isolates - 25 different other resistance 
genes were found, including sulphonamides (11 puppies had sul2, two puppies 
had sul1), tetracycline resistance genes (nine puppies had tet(B) and four 
puppies had tet(A), as well as other resistance genes floR, fosA7, mph(A), 
dfrA17, cat1A, catB4, dfrA1 and dfra14 (Table 5.4). This is a similar finding to a 
previous paper looking at resistance in adult dogs which found resistance genes 
like the ones found in this study and in this paper they stated that some of these 
resistance genes are also commonly identified in human isolates (Wedley et al. 
2017). The resistance genes dfrA1, dfrA17 and dfrA14 are responsible for 
trimethoprim resistance and were detected in five of the 16-week-old puppies 
and have been previously detected in other studies that have isolated E. coli and 
found them to be of animal origin (Wedley et al. 2011). The resistance genes 
qnrB4, qnrS1, qnrS2 and aac(6’)lb-cr were detected in the E. coli isolated from 
the 16-week-old puppies (Table 4.7); these are fluoroquinolone resistance genes 
and give low level resistance to quinolones (Martinez-Martinez et al. 1998; 
Wedley et al. 2011).  
It was possible in this study to predict whether the E. coli carried by the puppies 
were resistant to any other antibiotics using the sequencing data. These data 
suggested the potential for multidrug resistance (resistance to three or more 
classes of antimicrobials) in some of the puppies. Of the 20 cefotaxime-resistant 
E. coli colonies sequenced, 16 had resistance genes that potentially could cause 
resistance to three or more different classes of antimicrobials (Table 5.4). For 
example, the E. coli obtained from puppy 16 had resistance genes sul2, tet(B), 
mph(A), dfrA17, catA1, aadA5, strA, strB and aac(6’)lb-cr which confer resistance 





Table 5.4 Other resistance genes detected during the sequencing of cefotaxime-
resistant E. coli obtained from 16-week-old puppies. For each of the puppies, the 
other resistance genes that were detected and the resistance that each gene 
corresponds to are shown. The puppies with E. coli that was potentially multidrug-
resistant are also included.   
Other resistance 
genes detected 
16-week-old puppy samples 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
Sulphonamide 
resistance genes 








Y  Y Y  Y  Y   Y Y Y   Y  Y Y  
                     
Tetracycline 
resistance gene 








  Y Y  Y     Y Y Y   Y  Y Y  
                     
Macrolide 
resistance genes 





        Y   Y    Y     
                     
Fluoroquinolone 
Resistance 




16-week-old puppy samples 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
Genes 
qnrB4         Y            
qnrS1          Y   Y        
qnrS2                    Y 
aac(6’)lb-cr                 Y   Y 






















  Y Y  Y  Y   Y Y Y   Y  Y Y  
aph(3’)-Ia – 
aminoglycoside 
resistance gene  




                Y   Y 
aac(3)-IIa  - 
aminoglycoside 
resistance gene 
                Y    
                     




16-week-old puppy samples 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
genes 
floR – florfenicol 
resistance gene 
Y     Y             Y Y 
fosA7 – fosfomycin 
resistance gene 
























                   Y 
arr-3 – rifamycin 
resistance gene 
                   Y 




Y Y Y Y  Y  Y Y Y Y Y Y   Y Y Y Y Y 
 
It was also possible to have the 16-week-old ciprofloxacin-resistant puppy E. coli 
whole genome sequenced. Twenty samples were sent off for sequencing and 
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the STs, b-lactamase genes and other resistance genes were detected.  
There were 12 different STs identified from the 20 different 16-week-old puppies, 
indicating that there are a variety of different sequence types associated with 
ciprofloxacin-resistant E. coli. ST744 was the most common ST and was found 
in ten different puppies. This ST has previously been found in multidrug resistant 
E. coli obtained from dogs, suggesting that this ST is commonly found in dogs 
(Wagner et al. 2014). Many STs have been found in a wide variety of different 
animals and environments including humans, companion animals, wild animals, 
livestock, poultry and the environment which is evidence that many of the STs 
are found in many different places and not exclusively found in a particular 
species.  
The E. coli isolated from the 16-week-old puppies that were ciprofloxacin-
resistant were sequenced.  Out of the 20 puppies whose ciprofloxacin resistant 
E. coli was sequenced, 12 were raw fed, and there were a variety of STs for these 
puppies (Table 5.5, Table 5.6). All of the raw-fed puppy sequence types have 
previously been found in poultry and birds which could be evidence that the 16-
week-old puppies are acquiring resistant E. coli from eating raw poultry. It should 
be noted, however, that many of the STs are widespread and found in a variety 
of different species and environments. It is possible that the variety of different 
STs found in the ciprofloxacin-resistant E. coli from raw-fed puppies are the result 
of a variety of different STs in E. coli found in raw dog food, however, survey and 
testing of raw dog food would be required to establish this. Previous research 
has strongly suggested that feeding a dog raw food greatly increases the risk of 
the carriage of resistance, especially ciprofloxacin resistance (Schmidt et al. 
2015; Wedley et al. 2017). This study presents yet more evidence that the 
puppies could be obtaining resistant E. coli from raw poultry meat as the STs 
identified are also found in poultry. 
A previous study that investigated raw feeding in household cats also found that 
feeding raw food was a risk factor for ESBL shedding and that ESBL-producing 
Enterobacteriacea was often found to contaminate raw pet food (Baede et al. 
2017). In this study the authors found that 77.8% of all investigated raw pet food 
was contaminated with viable ESBLs, yet none of the non-raw pet food was 
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contaminated with these bacteria (Baede et al. 2017). This provides further 
evidence that the raw food may be spreading resistance to companion animals.  
Studies in the past have found that E. coli obtained from dogs and cats possess 
the same ESBL-encoding genes as well as the same STs as those from humans 
(Baede et al. 2017). The STs identified in the puppies in this study are found in a 
variety of different environments and animals, therefore further work may need 
to be done to assess whether the E. coli from the raw fed dogs originated from 
poultry. However, raw feeding dogs has been shown to be a risk factor for AMR 
and the ST results presented here provide further evidence for this (Chapter 3; 
Wedley et al. 2017). There is a possibility that dog owners may contaminate 
themselves with raw food whilst they are preparing their dogs’ food and this may 
contribute to household transmission of AMR, hence it is important that owners 
are aware of this potential risk (Baede et al. 2017).  
ST744 was found in seven E. coli obtained from 16-week-old puppies that were 
raw fed and was also found in three puppies that were not raw fed (Table 5.6). 
Some STs, however, were only found in puppies that were raw fed (ST1011, 
ST1196, ST1431, ST58, ST453, ST117, ST1775; Table 5.6). Some E. coli 
sequence types are more similar than others and using the seven MLST 
housekeeping genes it is possible to compare the relatedness of different 
sequence types (Lukjancenko et al. 2010). For example, ST744 and ST162 are 
fairly similar as 744 has adk_10 and 162 has adk_9 suggesting that these STs 
are more related than other STs (e.g. ST117 adk_20; Table 5.6). Both of these 
E. coli STs were commonly found in the puppies suggesting that they are 
common in dogs (Table 5.6). Therefore, the ST results may support the assertion 
that raw feeding is a risk factor for resistance, as the same STs have been in the 
puppies and previously found in poultry however, more work is needed. 
The risk factor analysis in Chapter 3 showed that there are other potential risk 
factors associated with ciprofloxacin resistance, hence raw food does not explain 
all of the resistance found in the E. coli carried by the 16-week-old puppies. 
Playing in lake water was also found to be a risk factor for ciprofloxacin resistance 
(Chapter 3), however, only six of the 26 E. coli samples sent off for sequencing 
were obtained from puppies that played in lake water (Table 5.2). There was no 
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strong correlation found between puppies that swam in lake water and certain 
STs.  
It was also possible to compare the STs in the cefotaxime-resistant E. coli carried 
by the 16-week-old puppies and the ciprofloxacin-resistant E. coli. ST58, ST1196 
and ST744 were found in both the cefotaxime- and ciprofloxacin-resistant E. coli 
however, the other STs were only found in one or the other (Table 5.2 and Table 
5.5).  
 
Table 5.5 Sequence types found in the ciprofloxacin-resistant E. coli from the 16-
week-old puppy samples including possible other sources where the sequence 
type has been found before using Enterobase. Results from the questionnaire 
data of whether these puppies were raw fed or whether they played in lake water 









Raw fed? Played 
in lake 
water? 
18 7366 Human No No 
19 162 Companion Animal, 












Yes  No 




21 162 Companion Animal, 






























Animal, Water, Avian 
Yes Yes 





























24 162 Companion Animal, 














































30 4988 Human No No 
31 162 Companion Animal, 





















Table 5.6 Sequence types found in the ciprofloxacin-resistant E. coli from the 16-
week-old puppy samples. Questionnaire data of whether these puppies were raw 
fed or not are included to show the number of times each sequence type is found 
in the E. coli carried by the dogs that are raw fed or non-raw fed (some puppies 
had more than one E. coli sequenced; Chapter 3). 
Sequence Type and 
genes 


































224 0 1 
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Sequence Type and 
genes 
Raw fed (n=16) Non-raw fed (n=7) 
adk_6, fumc_4, 
gyrb_33, icd_16, 





























The ciprofloxacin resistant E. coli isolated from the 16-week-old puppies 
underwent whole genome sequencing which allowed the comparison of its ST 
with the resistance mechanism to assess for any correlation (Table 5.7). 
Mutational-driven resistance was more common than horizontal gene transfer in 
the ciprofloxacin-resistant E. coli and only three of the E. coli tested had 
resistance involving horizontal gene transfer. The results show that all the E. coli 
with ST 162 (n=5) had chromosomal mutations in DNA topoisomerase genes that 
confer ciprofloxacin resistance. For ST744, eight E. coli had chromosomal 
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mutations that conferred ciprofloxacin resistance and three E. coli had mobile 
genetic elements which conferred ciprofloxacin resistance (Table 5.7). The only 
other ST with horizontal gene transfer involved in the resistance mechanism was 
ST4988 (Table 5.7).  
 
Table 5.7 Sequence types found in the ciprofloxacin-resistant E. coli from the 16-
week-old puppy samples. The results from MLST show the mechanisms for 
resistance, whether resistance was likely to be mutational driven resistance or 
through horizontal gene transfer (Chapter 3). 









qnr and aac-6’-CR 
744 8 2 
162 5 0 
4988 0 1 
1011 1 0 
1196 1 0 
1431 1 0 
224 1 0 
58 1 0 
453 1 0 
117 1 0 
1775 1 0 
7366 1 0 
 
Resistance genes were detected through the sequencing of the ciprofloxacin-
resistant E. coli that was obtained from 16-week-old puppies (Table 5.8). There 
were 27 resistance genes detected (Table 5.8). Three of the ciprofloxacin 
resistant E. coli isolated from the 16-week-old puppies carried a qnrS1 gene 
which confers fluoroquinolone resistance (Table 5.8). This plasmid-mediated 
 79 
resistance occurs as the qnr gene may block the action of quinolones and usually 
confers low levels of resistance but may provide a background for the selection 
of additional chromosomal mutation-driven resistance (Fàbrega et al. 2009). 
The remainder of the ciprofloxacin-resistant E. coli (n=19) carried by the puppies 
were likely to be due to chromosomal mutations through gyrA and parC mutations 
which confer AMR (Fàbrega et al. 2009; Table 5.8). Resistance occurs as a result 
of alterations in the target enzyme (DNA gyrase and topoisomerase IV) or 
because of a reduction of drug accumulation (Jacoby, 2009) This suggests that 
the majority of ciprofloxacin-resistant E. coli found in the 16-week-old puppies 
arose due to chromosomal mutation driven resistance (Table 5.7).  
Of the 20 puppy E. coli sequenced, 16 carried the resistant gene sul2 which 
confers resistance to sulphonamides. The spread of AMR has been attributed to 
class 1 and class 2 integrons and the sul1 gene is normally linked to other 
resistance genes in class 1 integrons (Antunes et al. 2005), which may be a 
reason for the widespread of this gene in the ciprofloxacin-resistant E. coli 
obtained in this study. Resistance to multiple antimicrobials is associated with 
integrons which acquire and spread resistance genes. Sulphonamides are also 
known to have been used alone and in combination with trimethoprim to treat 
small animals (Chang et al. 2014).  
The resistance gene tet(B) was also widespread and found in 13 of the 20 
sequenced E. coli. This gene confers tetracycline resistance (Table 5.8). 
Tetracycline resistance genes have been commonly found in other studies in 
dogs and some have suggested this is due to the mobile nature of the resistance 
mechanism (Wedley et al. 2011). It has also been suggested that tetracyclines 
are regularly used on dogs, hence contributing to the amount of tetracycline 
resistance genes (Wedley et al. 2017). 
No aminoglycoside resistance genes were detected in the ciprofloxacin-resistant 
E. coli and a possible explanation for this could be that aminoglycoside usage in 
dogs is low, therefore there are low levels of resistance (Radford et al. 2011; 
Table 5.8). Often, the mechanism for aminoglycoside resistance is via mobile 
genetic elements (Garneau-Tsodikova et al. 2016).  
Multidrug resistance is when more than three different classes of antibiotic 
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resistance can be detected in a bacterium. Out of the 19 ciprofloxacin-resistant 
E. coli sequenced, 18 had genes that confer resistance for three or more different 
antibiotic classes. Therefore, 18 out of 19 of the puppy E. coli tested were 
potentially multidrug resistant (Table 5.8).  
 
Table 5.8 Resistance genes detected during the sequencing of the ciprofloxacin-










































                   
blaTEM-1c         Y           
blaTEM-1B  Y Y  Y Y Y Y Y  Y  Y Y  Y  Y Y 
blaCARB-2         Y           
blaCTX-M-1        Y    Y        
blaCTX-M-15                 Y   
                    
Sulphonamide 
resistance genes 
                   
sul1 - sulphonamide 
resistance gene 
 Y  Y Y Y Y Y  Y  Y   Y   Y  
sul2 – sulphonamide 
resistance gene 
Y Y Y Y Y Y Y Y  Y Y Y  Y Y Y  Y Y 
sul3 – sulphonamide 
resistance gene 
      Y        Y     
                    
Tetracycline 
resistance genes 








































tet(A) – tetracycline 
resistance gene 
 Y  Y    Y      Y Y Y   Y 
tet(B) – tetracycline 
resistance gene 
Y Y Y  Y Y Y Y  Y Y Y Y    Y Y  
tet(L) – tetracycline 
resistance gene 
            Y       
tet(M) – tetracycline 
resistance gene 
            Y       
                    
Macrolide 
resistance genes 
                   
mph(A) – macrolide 
phophotansferases 
resistance gene 




            Y       
msr (C) -  
Erythromycin 
resistance gene 
            Y       
                    
Fluoroquinolone 
resistance genes 
                   
qnrS1       Y       Y    Y  
                    
Other resistance 
genes 






            Y       
dfrA1 – trimethoprim 
resistance gene 








































dfrA5 – trimethoprim 
resistance gene 
      Y       Y      
dfrA7 – trimethoprim 
resistance gene 
























      Y        Y     
floR –  florfenicol 
resistance gene 
  Y           Y    Y  




Y Y Y Y Y Y Y Y  Y Y Y Y Y Y Y Y Y Y 
 
In Chapters 3 and 4 it was found that amoxicillin resistance in the E. coli carried 
by 16-week-old puppies and adult dogs was lower in the locally recruited cohorts 
of dogs compared to the national cohorts of dogs (Chapter 3 and 4). Using the 
results in this chapter it was possible to compare the locally recruited 16-week-
old puppies with the Generation Pup recruited puppies to see whether there were 
differences in the PCR and whole genome sequence results. Chi-squared tests 
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were carried out, however, no differences were detected between the local and 
national results for cefotaxime and ciprofloxacin resistance genes. However, in 
Chapters 3 and 4, it was amoxicillin resistance that showed the significant 
difference and this was not analysed in this chapter. 
In conclusion, the sequence data provides further evidence of AMR in dogs. The 
STs found further implicate raw feeding of dogs and suggest a possible route of 
transmission as these STs have been found in both companion animals and 
poultry. The risk factor analysis in Chapter 3 highlighted some potential risk 
factors that contributed to AMR in E. coli carried by 16-week-old puppies and 
showed that raw feeding a puppy increased their risk of carrying AMR E. coli, 
however, it also showed that there were other associated risk factors. The genes 
found in the E. coli further reveal the mechanisms of resistance and that some 
resistance genes are found more commonly than others in the E. coli obtained 
from the dogs. As a result of this study, there is a set of 12-week-old, 16-week-
old and adult dog faecal samples that can be used in future investigations. There 
is also a database of whole genome sequence results and PCR results from the 
E. coli obtained from the puppy and dog faecal samples that could be used to 
compare to other datasets including AMR in the environment, cattle, and 
humans. It may also be possible to whole genome sequence AMR E. coli found 
in raw dog food and compare these sequences to those found in the E. coli from 
the raw fed puppy samples.  
In this chapter, only the 16-week-old puppy samples with E. coli that were 
cefotaxime- and ciprofloxacin-resistant had PCRs and were whole genome 
sequencing carried out. Further work could sequence the amoxicillin-resistant E. 
coli from the puppy samples to detect b-lactamase genes, determine the ST and 
provide evidence of the resistance mechanisms. In Chapters 3 and 4, amoxicillin 
resistance in the E. coli found in the puppies and dogs was shown to be 
significantly different in some of the various cohorts of dogs recruited, therefore 
this could provide evidence of transmission and acquisition of AMR E. coli in dogs 
and puppies. Further work could also be to survey the different types of raw food 
diet that dog owners feed to their dogs and then to whole genome sequence the 
E. coli found in various different types and brands of raw dog food to assess 
whether the STs and resistance genes are similar in the different types. It would 
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also be possible to compare the resistance genes, mechanisms and STs found 
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Figure 1. The questionnaire provided to 16-week-old puppy owners via 
Generation Pup. The questionnaire was completed and sent alongside a faecal 
sample collected from their puppy. 
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Figure 2. The questionnaire provided to owners of locally recruited 12-week-old 
puppies. The questionnaire was completed and sent alongside a faecal sample 




















Figure 3. The second questionnaire provided to the locally recruited puppy owners when their puppy was 16 weeks old. The 



















Figure 4. The questionnaire provided to locally recruited adult dog owners. The questionnaire was completed and sent alongside a 
faecal sample collected from the dog. 
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Table 1. Univariable risk factor analyses using questionnaire data and AMR E. coli data for 16-week-old puppies recruited locally and 
via Generation Pup (excluding samples with a limit of detection issue where the E. coli count was less than 20 cfu; n=223). Odds 
ratio (95% confidence interval) p-value. P-value considered significant if below 0.05.  
 






















4.47 (2.21 to 
9.05) <0.001 
3.30 (1.64 to 
6.63) 0.001 
1.97  (0.86 to 
4.51) 0.11 
8.23 (3.95 to 
17.15) <0.001  
Walked in town 0.65 (0.33 to 
1.28) 0.21 
3.06 (0.69 to 
13.48) 0.14 
0.63 (0.32 to 
1.25) 0.18 
0.74 (0.38 to 
1.46) 0.39 
0.88 (0.35 to 
2.18) 0.78 




1.02  (0.59 to 
1.76) 0.95 
1.63 (0.66  to 
4.07) 0.29 
1.04 (0.59 to 
1.83) 0.90 
1.06 (0.61 to 
1.85) 0.83 
1.05 (0.49 to 
2.26) 0.89 




1.17 (0.69 to 
1.97) 0.57 
2.44 (1.04 to 
5.74) 0.04 
1.55 (0.89 to 
2.68) 0.12 
1.00 (0.59 to 
1.71) 0.99 
1.38 (0.66 to 
2.86) 0.39 




1.45 (0.68 to 
3.09) 0.34 
2.16 (0.48 to 9.60) 
0.31 
2.26 (0.93 to 
5.49) 0.07 
1.23 (0.57 to 
2.65) 0.60 
1.87 (0.54 to 
5.53) 0.33 




0.75 (0.44 to 
1.30) 0.31 
0.57 (0.23 to 1.43) 
0.23 
0.88 (0.50 to 
1.55) 0.66 
0.73 (0.42 to 
1.27) 0.26 
1.19 (0.57 to 
2.50) 0.65 






played in salt 
water 
1.19 (0.66 to 
2.14) 0.56 
1.74 (0.74 to 4.08) 
0.20 
1.53 (0.84 to 
2.78) 0.17 
1.11 (0.61 to 
2.01) 0.73 
1.29 (0.59 to 
2.84) 0.52 
0.75 (0.36 to 
1.55) 0.44 
Swum/ paddled/ 
played in lake 
water 
1.60 (0.73 to 
3.54) 0.24 
3.72 (1.44 to 
9.61) 0.007 
2.01 (0.95 to 
4.56) 0.07 
1.87 (0.85 to 
4.11) 0.12 
1.97 (0.77 to 
5.05) 0.16 
1.96 (0.85 to 
4.55) 0.12 
Swum/ paddled/ 
played in river 
water 
1.09 (0.62 to 
1.94) 0.76 
1.57 (0.67 to 3.68) 
0.30 
1.10 (0.61 to 
1.99) 0.75 
1.14 (0.64 to 
2.04) 0.66 
0.57 (0.24 to 
1.39) 0.22 
0.99 (0.50 to 
1.96) 0.97 
Swum/ paddled/ 
played in pond 
water 
1.77 (0.99 to 
3.18) 0.06 
1.94 (0.84 to 4.49) 
0.12 
1.80 (1.00 to 
3.25) 0.05 
2.01 (1.12 to 
3.61) 0.02 
1.40 (0.65 to 
3.03) 0.39 
1.29 (0.66 to 
2.53) 0.46 
Rolled in cowpat 4.83 (0.55 to 
42.21) 0.15 
 
1.34 (0.15 to 
11.98 ) 0.79 
3.13 (0.56 to 
17.55) 0.20 
6.35 (0.73 to 
55.44) 0.10 
5.56 (1.06 to 
28.98) 0.04 
6.63 (1.17 to 
37.53) 0.03 
Rolled in fox 
faeces 
0.73 (0.19 to 
2.81) 0.65 
 
0.82 (0.10 to 6.87) 
0.86 
0.74 (0.18 to 
3.07) 0.68 
0.96 (0.25 to 
3.70) 0.96 
0.66  (0.08 to 
5.19) 0.66 




behaviour in past 
seven days 
0.28 (0.09 to 
0.90) 0.03 
--------- 0.19 (0.04 to 
0.88) 0.03 




Table 2. Multivariable risk factor analyses using questionnaire data and AMR E. coli data for 16-week-old puppies recruited locally 
and via Generation Pup (excluding samples with a limit of detection issue where the E. coli count was less than 20 cfu; n=223). Odds 
ratio (95% confidence interval) p-value. P-value considered significant if below 0.05.  
 


















Fed raw food 3.88 (1.73 to 
8.70) 0.001 
11.32 (4.05 to 
31.63) <0.001 
4.18 (1.94 to 
9.03) <0.001 
3.14 (1.47 to 
6.71) 0.003 
1.72  (0.69 to 
4.28) 0.24 
7.84 (3.48 to 
17.65) <0.001  
Walked in town 0.71 (0.34 to 
1.46) 0.35 
4.22 (0.86 to 
20.82) 0.08 
0.60 (0.29 to 
1.28) 0.19 
0.89 (0.43 to 
1.81) 0.74 
0.86 (0.33 to 
2.24) 0.77 




0.81 (0.37 to 
1.77) 0.60 
1.22 (0.34  to 4.40) 
0.76 
0.56 (0.25 to 
1.27) 0.17 
1.04 (0.48 to 
2.28) 0.92 
0.78 (0.28 to 
2.18) 0.64 




1.05 (0.48 to 
2.31) 0.90 
1.77 (0.47 to 6.68) 
0.40 
1.35 (0.59 to 
3.10) 0.48 
0.83 (0.37 to 
1.86) 0.66 
1.33 (0.47 to 
3.76) 0.60 




1.32 (0.52 to 
3.34) 0.56 
0.92 (0.15 to 5.79) 
0.93 
2.30 (0.80 to 
6.61) 0.12 
0.93 (0.36 to 
2.39) 0.89 
1.77 (0.42 to 
7.37) 0.33 




0.81 (0.41 to 
1.61) 0.55 
0.47 (0.15 to 1.45) 
0.19 
1.02 (0.50 to 
2.12) 0.92 
0.73 (0.37 to 
1.47) 0.38 
1.38 (0.55 to 
3.44) 0.49 




played  in salt 
water 
1.06 (0.43 to 
2.59) 0.90 
0.95 (0.25 to 3.66) 
0.94 
1.19 (0.47 to 
3.01) 0.71 
1.06 (0.43 to 
2.63) 0.90 
1.07 (0.34 to 
3.36) 0.90 















played  in lake 
water 
0.85 (0.34 to 
2.15) 0.74 
1.28 (0.38 to 4.26) 
0.69 
1.03 (0.41 to 
2.60) 0.95 
1.11 (0.45 to 
2.73) 0.81 
1.58 (0.53 to 
4.70) 0.41 




played  in river 
water 
0.95 (0.48 to 
1.90) 0.89 
1.04 (0.33 to 3.26) 
0.07 
0.85 (0.41 to 
1.75) 0.66 
0.96 (0.48 to 
1.92) 0.90 
0.38 (0.14 to 
1.05) 0.06 




played in pond 
water 
1.66 (0.83 to 
3.33) 0.15 
1.64 (0.54 to 4.98) 
0.39 
1.50 (0.73 to 
3.06) 0.27 
1.95 (0.98 to 
3.90) 0.06 
1.41 (0.57 to 
3.50) 0.45 
1.19 (0.51 to 
2.75) 0.69 
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Table 3. Multivariable risk factor analyses using questionnaire data and AMR E. coli data for 16-week-old puppies recruited via 
Generation Pup (excluding samples with a limit of detection issue where the E. coli count was less than 20 cfu; n=182). Odds ratio 
(95% confidence interval) p-value. P-value considered significant if below 0.05.  
 


















Fed raw food 3.32 (1.39 to 
7.95) 0.007 
9.82 (3.26 to 
29.54) <0.001 
3.71 (1.58 to 
8.67) 0.003 
2.33 (1.03 to 
5.27) 0.04 
1.16  (0.43 to 
3.14) 0.77 
6.93 (2.83 to 
16.98) <0.001  
Walked in town 0.79 (0.36 to 
1.71) 0.54 
4.59 (0.90 to 
23.30) 0.07 
0.61 (0.27 to 
1.37) 0.23 
1.06 (0.49 to 
2.30) 0.88 
1.06 (0.39 to 
2.88) 0.91 




0.88 (0.37 to 
2.11) 0.77 
1.42 (0.37 to 5.43) 
0.61 
0.55 (0.22 to 
1.35) 0.19 
1.18 (0.49 to 
2.80) 0.72 
1.15 (0.37 to 
3.53) 0.81 




0.72 (0.28 to 
1.86) 0.50 
1.40 (0.31 to 6.41) 
0.66 
0.81 (0.30 to 
2.21) 0.68 
0.68 (0.26 to 
1.76) 0.43 
1.83 (0.53 to 
6.33) 0.34 




1.24 (0.37 to 
4.15) 0.72 
1.07 (0.10 to 
11.68) 0.95 
4.65 (1.05 to 
20.63) 0.04 
1.03 (0.31 to 
3.46) 0.96 
0.65 (0.14 to 
3.04) 0.58 




0.71 (0.32 to 
1.57) 0.40 
0.40 (0.28 to 5.52) 
0.78 
0.88 (0.38 to 
2.03) 0.76 
0.57 (0.25 to 
1.26) 0.16 
0.69 (0.23 to 
2.06) 0.51 
0.23 (0.08 to 
0.65) 0.006 
Swum/ paddled/ 
played  in salt 
water 
1.68 (0.59 to 
4.79) 0.33 
0.98 (0.27 to 3.51) 
0.97 
2.12 (0.71 to 
6.31) 0.18 
1.30 (0.46 to 
3.70) 0.62 
1.25 (0.35 to 
4.52) 0.73 






played  in lake 
water 
0.70 (0.25 to 
1.95) 0.50 
1.38 (0.42 to 4.50) 
0.59 
0.74 (0.26 to 
2.07) 0.56 
1.94 (0.35 to 
2.54) 0.90 
1.31 (0.40 to 
4.29) 0.65 
0.65 (0.19 to 
2.14) 0.48 
Swum/ paddled/ 
played  in river 
water 
0.86 (0.40 to 
1.84) 0.70 
1.64 (0.42 to 4.50) 
0.59 
0.85 (0.38 to 
1.89) 0.70 
0.75 (0.35 to 
1.63) 0.47 
0.36 (0.12 to 
1.10) 0.07 
0.81 (0.30 to 
2.16) 0.67 
Swum/ paddled/ 
played in pond 
water 
1.66 (0.77 to 
3.56) 0.19 
1.64 (0.53 to 5.08) 
0.39 
1.69 (0.77 to 
3.72) 0.19 
1.91 (0.89 to 
4.10) 0.10 
1.53 (0.58 to 
4.01) 0.39 
1.07 (0.43 to 
2.65) 0.88 
Rolled in cow 
pats 
3.84 (0.36 to 
40.64) 0.26 
 
0.95  (0.05 to 
16.92) 0.97 
1.91 (0.24 to 
14.99) 0.54 
6.06 (0.59 to 
62.31) 0.13 
9.50 (1.27 to 
71.05) 0.03 
12.16 (1.49  to 
99.49) 0.02 
Rolled in fox 
faeces 
0.60 (0.14 to 
2.61) 0.50 
 
0.33 (0.02 to 4.59) 
0.41 
0.61 (0.13 to 
2.87) 0.53 
0.77 (0.18 to 
3.36) 0.73 
0.73 (0.08 to 
6.76) 0.78 





past seven days 
0.21 (0.05 to 
0.82) 0.02 
--------- 0.09 (0.01 to 
0.76) 0.03 





Table 4.   Univariable risk factor analyses using questionnaire data and AMR E. coli data for 12-week-old puppies (excluding samples 
with a limit of detection issue where the E. coli count was less than 20 cfu; n=64). Odds ratio (95% confidence interval) p-value. P-
value considered significant if below 0.05. The questionnaire answers were of where the owner intended to walk their puppy when 
the puppy was old enough to walk in public places. 
 

















Fed raw food 2.90 (0.28 to 
29.51) 0.37 
4.50 (0.38 to 
53.77) 0.24 
1.28 (0.12 to 
13.41) 0.84 
3.00 (0.29 to 
30.56) 0.35 
2.48 (0.23 to 
27.32) 0.46 




NT NT NT NT NT NT 
Walked in 
parks 
0.69 (0.11 to 
4.45) 0.70 
0.31 (0.03 to 3.45) 
0.34 
0.98 (0.10 to 
9.64) 0.99 
0.67 (0.10 to 
4.30) 0.67 
0.18 (0.02 to 
1.28) 0.09 




0.52 (0.09 to 
3.06) 0.47 
0.38 (0.04 to 4.14) 
0.43 
NT 0.50 (0.08 to 
2.95) 0.44 






1.54 (0.31 to 
7.52) 0.60 
NT 1.67 (0.18 to 
15.29) 0.65 







2.80 (0.83 to 
9.46) 0.10 
0.44 (0.07 to 2.94) 
0.40 
1.99 (0.39 to 
10.18) 0.41 
2.70 (0.80 to 
9.14) 0.11 
2.39 (0.27 to 
21.17) 0.43 





2.25 (0.70 to 
7.22) 0.17 
0.49 (0.07 to 3.23) 
0.46 
2.20 (0.43 to 
11.22) 0.34 
2.17 (0.67 to 
6.97) 0.19 
2.63 (0.30 to 
23.17) 0.39 

















Table 5.  Multivariable risk factor analyses using questionnaire data and AMR E. coli data for 12-week-old puppies (excluding samples 
with a limit of detection issue where the E. coli count was less than 20 cfu; n=64). Odds ratio (95% confidence interval) p-value. P-
value considered significant if below 0.05. The questionnaire answers were of where the owner intended to walk their puppy when 
the puppy was old enough to walk in public places. 
 

















Fed raw food 1.70 (0.14 to 
20.37) 0.68 
25.81 (0.94 to 
710.72) 0.06 
NT 1.79 (0.15 to 
21.49) 0.65 
6.13 (0.41 to 
91.57) 0.19 




NT NT NT NT NT NT 
Walked in 
parks 
0.67 (0.10 to 
4.58) 0.68 
0.06 (0.002 to 
1.45) 0.08 
0.96 (0.09 to 
10.57) 0.97 
0.65 (0.10 to 
4.41) 0.66 
0.08 (0.008 to 
0.83) 0.03 




0.20 (0.02 to 
2.22) 0.19 
0.08 (0.004 to 
1.89) 0.12 
NT 0.20 (0.02 to 
2.16) 0.19 






4.40 (0.36 to 
53.65) 0.25 
 















NT NT NT NT NT NT 













Table 6. Univariable risk factor analyses using questionnaire data and AMR E. coli data for adult dogs recruited locally (excluding 
samples with a limit of detection issue where the E. coli count was less than 20 cfu; n=14). Odds ratio (95% confidence interval) p-
value. P-value considered significant if below 0.05. 
 



















0.08 (0.01 to 
1.29) 0.08 
0.33 (0.02 to 7.14) 
0.48 
0.25 (0.02 to 
3.04) 0.28 
0.11 (0.01 to 
1.92) 0.13 




0.83 (0.09 to 
7.68) 0.87 
NT 1.50 (0.15 to 
15.46) 0.73 
3.50 (0.24 to 
51.90) 0.36 




0.21 (0.01 to 
3.37) 0.27 
0.22 (0.01 to 5.28) 
0.35 
0.13 (0.01 to 
2.18) 0.15 
0.50 (0.03 to 
8.71) 0.63 






















0.50 (0.02 to 
10.25) 0.65 






played in salt 
water 
0.83 (0.09 to 
7.68) 0.87 
1.4 (0.07 to 28.12) 
0.83 
1.50 (0.15 to 
15.46) 0.73 
0.60 (0.04 to 
8.73) 0.71 




played in lake 
water 
1.33 (0.14 to 
12.82) 0.80 
2.00 (0.10 to 
41.00) 0.65 
2.33 (0.22 to 
25.24) 0.49 
0.88 (0.06 to 
12.97) 0.92 




played in river 
water 
3.20 (0.25 to 
41.21) 0.37 





played in pond 
water 
1.88 (0.20 to 
17.27) 0.58 
NT 4.50 (0.34 to 
60.15) 0.26 










0.19 (0.01 to 
2.91) 0.23 
0.20 (0.01 to 4.72) 
0.32 
0.75 (0.05 to 
11.65) 0.84 
0.05 (0.002 to 
1.18) 0.06 
NT 0.44 (0.03 to 
7.67) 0.58 
NT = not tested due to collinearity (this is due to small sample size) 
 
 
